Sam A Borno, MD
Cardiovascular Disease (Cardiology) · Fresno
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Offices
- 3
- Since medical school
- 44 years
- Graduated 1982
Offices
3 locations · Cardiac Institute of Central California A Medical Corporation · 2 clinicians in this group
Looking this up.
Hospitals listed: Community Regional Medical Center. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Borno’s office at (559) 256-5500 to ask if they take your plan before you enroll.
California Medical Board record
Licence A44967 · Current
Licensed to practise in California · since 1988 · expires 2028-05-31 · Tanta Faculty of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
School, training and certification
What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.
Specialty certification
- American Board of Internal Medicine - Cardiology
- American Board of Internal Medicine - Cardiovascular Disease
- American Board of Internal Medicine - Interventional Cardiology
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Community Regional Medical CenterFresno, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Community Medical Centers, which runs 4 hospitalsPatients rate it 3 of 5 · 70% would definitely recommend itOverall rating: 1 of 5 starsWorse than the national rate — Death rate among surgical inpatients with serious treatable complications: 211.21 (174.88 to 247.54) · 239 cases, Jul 2022 – Jun 2024Better than the national rate — Clostridium Difficile (C.Diff): 0.705, Oct 2024 – Sep 2025
See every measure and the patient survey for Community Regional Medical Center
Behind the star rating — Deaths: 0 better, 7 the same, 1 worse of 8 measures. Safety: 0 better, 7 the same, 0 worse of 7 measures. Readmissions: 0 better, 7 the same, 3 worse of 10 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 211.21 (174.88 to 247.54) · 239 cases | Worse | Jul 2022 – Jun 2024 |
| Clostridium Difficile (C.Diff)Infections | 0.705 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.13 (0.29 to 1.96) · 2,304 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.09 (0.87 to 1.3) | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 3.2 · 187 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 8.6 · 116 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.7 · 187 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 10.6 · 445 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 15.2 · 399 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.1 · 582 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.2 · 3,744 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.31 (0.12 to 0.5) · 11,052 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.27 (0.1 to 0.45) · 11,566 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.33 (1.64 to 5.01) · 3,139 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.08 (0 to 2.3) · 1,423 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 1.7 (0.52 to 2.88) · 3,084 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 11.85 (8.11 to 15.6) · 1,481 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 6.4 (3.81 to 8.98) · 1,404 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 2.35 (0.95 to 3.76) · 760 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.64 (0.16 to 1.11) · 10,254 cases | No different | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.817 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 1.031 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.837 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.81 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.853 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.8 · 258 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22 · 689 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 37.4 · 202 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 35.2 · 543 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 39.2 · 434 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 19.3 · 552 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.4 (3.6 to 7.9) · 169 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 11.4 (8.3 to 15.4) · 169 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission for CABGUnplanned return visits | 12.4 · 189 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 21.6 · 248 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 11.9 (9.5 to 14.9) · 2,590 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.7 to 1.2) · 310 cases | No different | Jan 2024 – Dec 2024 |
What patients said (421 patients answered, 26% of those asked)
| Cleanliness | 4 |
| Nurse communication | 2 |
| Doctor communication | 3 |
| Communication about medicines | 2 |
| Discharge information | 4 |
| Overall hospital rating | 3 |
| Quietness | 1 |
| Recommend hospital | 3 |
| Room was "always" clean | 74% |
| Nurses "always" communicated well | 74% |
| Doctors "always" communicated well | 77% |
| Staff "always" explained | 55% |
| Yes, staff "did" give patients this information | 87% |
| Yes, staff "did" give patients information about help after discharge | 85% |
| Doctors "always" explained things so they could understand | 71% |
| Doctors "always" listened carefully | 76% |
| Doctors "always" treated them with courtesy and respect | 83% |
| Patients who gave a rating of "9" or "10" (high) | 66% |
| Staff "always" explained new medications | 69% |
| Nurses "always" explained things so they could understand | 70% |
| Nurses "always" listened carefully | 70% |
| Nurses "always" treated them with courtesy and respect | 82% |
| "Always" quiet at night | 43% |
| "YES", patients would definitely recommend the hospital | 70% |
| Staff "always" explained possible side effects | 41% |
| Yes, staff "did" give patients information about possible symptoms | 88% |
Original Medicare doctor bills
$1,339,562
Medicare paid this office $1,339,562 for 2,178 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 1,871 | $292,448 | $93 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 745 | $263,079 | $352 |
| Electrocardiogram (ecg) up to 30 days continuous with transmission of patient triggered events with review and report by health care professional | 306 | $208,970 | $676 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 1,089 | $162,086 | $144 |
| Ultrasound of both sides of head and neck blood flow | 609 | $86,005 | $141 |
See all 31 services
| Return visit (30+ min) | 1,871 | $292,448 | $93 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 745 | $263,079 | $352 |
| Electrocardiogram (ecg) up to 30 days continuous with transmission of patient triggered events with review and report by health care professional | 306 | $208,970 | $676 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 1,089 | $162,086 | $144 |
| Ultrasound of both sides of head and neck blood flow | 609 | $86,005 | $141 |
| Insertion of heart rhythm monitor under skin | 18 | $61,848 | $3,436 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 740 | $56,354 | $38 |
| New patient visit (45+ min) | 427 | $46,325 | $108 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 751 | $43,719 | $58 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 1,833 | $21,374 | $10 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 304 | $16,450 | $53 |
| Injection, regadenoson, 0.1 mg | 677 | $14,575 | None |
| Programming of dual lead pacemaker system | 128 | $11,237 | $56 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 61 | $10,617 | $174 |
| Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | 308 | $5,856 | $19 |
| Short return visit (20+ min) | 95 | $5,853 | $60 |
| Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days | 25 | $5,228 | $36 |
| Programming of multiple lead implantable defibrillator system | 20 | $3,391 | $75 |
| Programming of dual lead implantable defibrillator system | 24 | $2,821 | $67 |
| Ultrasound of heart blood flow, valves and chambers | 60 | $2,475 | $41 |
| Long return visit (40+ min) | 25 | $2,432 | $90 |
| Evaluation of cardiac rhythm monitor system, remote up to 30 days | 20 | $2,249 | $37 |
| New patient visit (30+ min) | 32 | $2,248 | $70 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 43 | $1,810 | $19 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 62 | $1,809 | $17 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 23 | $1,176 | $27 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 60 | $1,160 | $19 |
| Evaluation of implantable heart and blood vessel monitoring system | 19 | $1,148 | $38 |
| Programming of single lead pacemaker system | 14 | $871 | $51 |
| Evaluation of cardiac rhythm monitor system | 11 | $478 | $40 |
| Injection, aminophyllin, up to 250 mg | 71 | $457 | None |
Procedures year by year
| Procedure | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Insertion of heart rhythm monitor under skin | – | – | – | – | – | 18 |
Times billed to Original Medicare each year. A blank year means fewer than 11 people had it, or none: Medicare does not publish smaller counts. Medicare Advantage patients are not included.
Who their Medicare patients are
2,178 Original Medicare patients in 2024. Average age 75 · Under 65 6% · 85 and older 13% · Women 50% · Also on Medicaid 28% · Health risk score 1.18. At or below the middle of the specialty; the typical cardiology clinician is at 1.71.
Conditions among them: High blood pressure 75% · Diabetes 43% · Coronary heart disease 35% · Chronic kidney disease 32% · Atrial fibrillation 23% · Heart failure 17% · Depression 16% · Cancer 14% · COPD 12% · Stroke 9% · Dementia 4%.
The office billed $3,692,701, Medicare allowed $1,778,345 and paid $1,339,562; for 15,270 services of 47 kinds; $15,032 of it was for drugs given in the office and $1,324,530 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 2,178 | 15,270 | 75 | 1.18 | $3,692,701 | $1,339,562 |
| 2023 | 2,270 | 14,137 | 75 | 1.14 | $3,403,099 | $1,347,913 |
| 2022 | 2,508 | 15,961 | 75 | 1.11 | $3,729,164 | $1,508,018 |
| 2021 | 2,610 | 16,638 | 75 | 1.15 | $3,929,855 | $1,613,186 |
| 2020 | 2,722 | 17,290 | 75 | 1.25 | $4,197,858 | $1,691,778 |
| 2019 | 3,137 | 19,011 | 75 | 1.18 | $4,546,824 | $1,815,978 |
| 2018 | 3,643 | 22,714 | 75 | 1.16 | $5,583,756 | $2,123,402 |
| 2017 | 3,641 | 26,424 | 75 | 1.20 | $6,447,482 | $2,530,389 |
| 2016 | 3,380 | 25,024 | 75 | 1.24 | $6,118,885 | $2,397,690 |
| 2015 | 3,187 | 22,056 | 75 | 1.21 | $5,339,608 | $2,142,179 |
| 2014 | 2,918 | 20,710 | 75 | 1.14 | $4,933,875 | $1,960,148 |
| 2013 | 2,900 | 20,679 | 75 | 1.14 | $5,030,058 | $1,948,318 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 30 services
| Electrocardiogram (ecg) up to 30 days continuous with transmission of patient triggered events with review and report by health care professional | 385 | $279,884 | $710 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 677 | $248,423 | $367 |
| Return visit (30+ min) | 1,596 | $193,618 | $91 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 994 | $147,952 | $146 |
| Injection, regadenoson, 0.1 mg | 590 | $102,835 | None |
| Ultrasound of both sides of head and neck blood flow | 656 | $95,675 | $146 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 663 | $49,632 | $37 |
| Short return visit (20+ min) | 613 | $43,576 | $68 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 691 | $40,173 | $58 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 397 | $22,610 | $56 |
| New patient visit (30+ min) | 299 | $20,395 | $68 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 1,793 | $19,951 | $10 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 106 | $19,752 | $186 |
| New patient visit (45+ min) | 116 | $13,703 | $118 |
| Programming of dual lead pacemaker system | 150 | $13,378 | $55 |
| Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | 384 | $7,501 | $19 |
| Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec | 32 | $5,514 | $69 |
| Ultrasound of heart blood flow, valves and chambers | 106 | $4,501 | $42 |
| Programming of multiple lead implantable defibrillator system | 23 | $4,143 | $77 |
| Programming of dual lead implantable defibrillator system | 21 | $2,175 | $59 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 106 | $2,117 | $20 |
| Programming of single lead pacemaker system | 22 | $1,786 | $48 |
| Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days | 24 | $1,473 | $20 |
| Evaluation of implantable heart and blood vessel monitoring system | 20 | $934 | $35 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 41 | $840 | $17 |
| Evaluation of cardiac rhythm monitor system, remote up to 30 days | 13 | $768 | $21 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 19 | $616 | $27 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 24 | $595 | $21 |
| Injection, aminophyllin, up to 250 mg | 78 | $572 | None |
| Evaluation of cardiac rhythm monitor system | 12 | $461 | $35 |
2022: 31 services
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 787 | $302,087 | $382 |
| Electrocardiogram (ecg) up to 30 days continuous with transmission of patient triggered events with review and report by health care professional | 345 | $267,279 | $759 |
| Return visit (30+ min) | 1,673 | $219,974 | $94 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 1,105 | $166,056 | $147 |
| Injection, regadenoson, 0.1 mg | 677 | $131,711 | None |
| Ultrasound of both sides of head and neck blood flow | 739 | $110,081 | $149 |
| Short return visit (20+ min) | 730 | $55,738 | $69 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 771 | $52,213 | $34 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 793 | $47,134 | $59 |
| New patient visit (30+ min) | 491 | $32,957 | $67 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 1,990 | $23,061 | $10 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 123 | $23,039 | $187 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 376 | $21,929 | $57 |
| Programming of dual lead pacemaker system | 156 | $14,137 | $58 |
| Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | 346 | $6,834 | $19 |
| Ultrasound of heart blood flow, valves and chambers | 123 | $5,377 | $44 |
| Programming of multiple lead implantable defibrillator system | 22 | $3,664 | $78 |
| Short return visit | 99 | $3,594 | $36 |
| Programming of dual lead implantable defibrillator system | 26 | $3,443 | $72 |
| Evaluation of implantable heart and blood vessel monitoring system | 49 | $2,824 | $36 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 123 | $2,525 | $21 |
| Programming of single lead pacemaker system | 26 | $1,638 | $48 |
| Programming of single lead implantable defibrillator system | 13 | $1,144 | $57 |
| Evaluation of cardiac rhythm monitor system, remote up to 30 days | 13 | $1,096 | $20 |
| Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days | 17 | $952 | $18 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system | 23 | $895 | $39 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 40 | $882 | $18 |
| Injection, aminophyllin, up to 250 mg | 103 | $747 | None |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 28 | $713 | $22 |
| Evaluation of cardiac rhythm monitor system | 13 | $611 | $38 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 14 | $487 | $29 |
2021: 32 services
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 808 | $328,636 | $404 |
| Return visit (30+ min) | 1,623 | $210,018 | $96 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 1,268 | $200,798 | $155 |
| Electrocardiogram (ecg) up to 30 days continuous with transmission of patient triggered events with review and report by health care professional | 292 | $178,961 | $609 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 796 | $143,115 | $89 |
| Injection, regadenoson, 0.1 mg | 750 | $142,101 | None |
| Ultrasound of both sides of head and neck blood flow | 747 | $120,596 | $161 |
| Short return visit (20+ min) | 819 | $60,003 | $69 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 813 | $48,747 | $59 |
| New patient visit (30+ min) | 487 | $38,445 | $79 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 163 | $31,900 | $196 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 2,015 | $24,619 | $11 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 334 | $20,928 | $62 |
| Programming of dual lead pacemaker system | 140 | $12,543 | $56 |
| Ultrasound of heart blood flow, valves and chambers | 162 | $7,380 | $46 |
| Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | 292 | $6,002 | $20 |
| Short return visit | 149 | $5,993 | $40 |
| Programming of multiple lead implantable defibrillator system | 22 | $3,679 | $82 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system | 70 | $3,611 | $36 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 162 | $3,490 | $22 |
| Programming of dual lead implantable defibrillator system | 26 | $3,088 | $74 |
| Evaluation of implantable heart and blood vessel monitoring system | 52 | $2,561 | $36 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system | 25 | $1,919 | $50 |
| Programming of single lead pacemaker system | 31 | $1,822 | $47 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 53 | $1,667 | $21 |
| Evaluation of cardiac rhythm monitor system, remote up to 30 days | 16 | $1,335 | $20 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 40 | $1,329 | $24 |
| New patient visit (45+ min) | 12 | $1,241 | $103 |
| Programming of single lead implantable defibrillator system | 14 | $1,172 | $47 |
| Evaluation of cardiac rhythm monitor system | 18 | $970 | $36 |
| Injection, aminophyllin, up to 250 mg | 122 | $841 | None |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 14 | $714 | $29 |
2020: 28 services
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 901 | $366,119 | $402 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 1,416 | $229,009 | $160 |
| Electrocardiogram (ecg) up to 30 days continuous with transmission of patient triggered events with review and report by health care professional | 299 | $186,862 | $611 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 898 | $176,093 | $97 |
| Return visit (30+ min) | 1,624 | $175,570 | $81 |
| Injection, regadenoson, 0.1 mg | 823 | $154,092 | None |
| Ultrasound of both sides of head and neck blood flow | 722 | $118,547 | $164 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 920 | $56,135 | $60 |
| Short return visit (20+ min) | 829 | $49,751 | $58 |
| New patient visit (30+ min) | 518 | $37,835 | $73 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 165 | $29,678 | $180 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 2,034 | $28,176 | $13 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 321 | $22,544 | $69 |
| Programming of dual lead pacemaker system | 147 | $12,276 | $48 |
| Ultrasound of heart blood flow, valves and chambers | 165 | $7,584 | $46 |
| Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | 299 | $6,556 | $21 |
| Programming of multiple lead implantable defibrillator system | 25 | $3,937 | $72 |
| Short return visit | 127 | $3,878 | $31 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 165 | $3,562 | $22 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system | 62 | $3,026 | $36 |
| New patient visit (45+ min) | 23 | $2,762 | $120 |
| Programming of dual lead implantable defibrillator system | 23 | $2,432 | $68 |
| Evaluation of implantable heart and blood vessel monitoring system | 51 | $2,348 | $31 |
| Programming of single lead pacemaker system | 31 | $2,226 | $45 |
| Programming of single lead implantable defibrillator system | 16 | $1,393 | $50 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system | 22 | $1,357 | $47 |
| Evaluation of cardiac rhythm monitor system | 19 | $1,264 | $33 |
| Injection, aminophyllin, up to 250 mg | 89 | $613 | None |
2019: 28 services
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 927 | $372,617 | $400 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 1,561 | $250,981 | $158 |
| Return visit (30+ min) | 1,991 | $222,569 | $81 |
| Electrocardiogram (ecg) up to 30 days continuous with transmission of patient triggered events with review and report by health care professional | 332 | $202,660 | $600 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 925 | $177,061 | $95 |
| Injection, regadenoson, 0.1 mg | 844 | $154,447 | None |
| Ultrasound of both sides of head and neck blood flow | 680 | $109,184 | $160 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 931 | $55,469 | $59 |
| Short return visit (20+ min) | 940 | $54,975 | $56 |
| New patient visit (30+ min) | 706 | $51,508 | $73 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 171 | $31,589 | $185 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 2,261 | $31,291 | $13 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 341 | $23,664 | $68 |
| Programming of dual lead pacemaker system | 177 | $19,364 | $47 |
| Ultrasound of heart blood flow, valves and chambers | 171 | $7,691 | $45 |
| Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | 332 | $6,681 | $20 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 26 | $5,543 | $213 |
| Programming of multiple lead implantable defibrillator system | 31 | $5,122 | $71 |
| Programming of dual lead implantable defibrillator system | 34 | $4,023 | $64 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system | 71 | $3,713 | $33 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 171 | $3,660 | $21 |
| Programming of single lead pacemaker system | 46 | $3,621 | $41 |
| Evaluation of implantable heart and blood vessel monitoring system | 53 | $2,737 | $31 |
| Evaluation of cardiac rhythm monitor system | 23 | $1,876 | $30 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system | 25 | $1,586 | $42 |
| Injection for imaging of aorta above heart valve with review by radiologist | 33 | $1,327 | $40 |
| Ultrasound study of arm and leg arteries | 14 | $1,013 | $72 |
| Injection, aminophyllin, up to 250 mg | 74 | $471 | None |
2018: 30 services
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 1,303 | $527,387 | $403 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 2,120 | $337,398 | $157 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 1,302 | $246,855 | $94 |
| Return visit (30+ min) | 2,089 | $223,570 | $79 |
| Injection, regadenoson, 0.1 mg | 1,186 | $209,378 | None |
| Ultrasound of both sides of head and neck blood flow | 747 | $122,037 | $162 |
| Electrocardiogram (ecg) up to 30 days continuous with transmission of patient triggered events with review and report by health care professional | 133 | $83,136 | $625 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 1,317 | $77,999 | $59 |
| Short return visit (20+ min) | 1,296 | $72,753 | $53 |
| New patient visit (30+ min) | 843 | $59,638 | $71 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 231 | $42,312 | $183 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 2,151 | $28,085 | $12 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 333 | $22,518 | $67 |
| Programming of dual lead pacemaker system | 175 | $16,039 | $43 |
| Ultrasound of heart blood flow, valves and chambers | 231 | $10,449 | $45 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 231 | $5,040 | $22 |
| Programming of multiple lead implantable defibrillator system | 29 | $4,116 | $62 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 20 | $4,039 | $202 |
| Programming of single lead pacemaker system | 51 | $4,019 | $37 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system | 88 | $3,614 | $27 |
| Programming of dual lead implantable defibrillator system | 31 | $2,931 | $55 |
| Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | 133 | $2,821 | $21 |
| Evaluation of implantable heart and blood vessel monitoring system | 53 | $2,572 | $27 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system | 32 | $1,845 | $38 |
| Ultrasound study of arm and leg arteries | 23 | $1,787 | $74 |
| Ultrasound of abdomen and pelvis artery and vein blood flow | 12 | $1,414 | $118 |
| Injection for imaging of aorta above heart valve with review by radiologist | 21 | $804 | $38 |
| Evaluation of cardiac rhythm monitor system | 12 | $691 | $22 |
| Electrocardiogram (ecg) 2-day continuous with report | 16 | $484 | $30 |
| Injection, aminophyllin, up to 250 mg | 77 | $406 | None |
2017: 36 services
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 1,738 | $698,267 | $401 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 2,158 | $381,545 | $176 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 1,739 | $329,431 | $95 |
| Injection, regadenoson, 0.1 mg | 1,647 | $284,375 | None |
| Return visit (30+ min) | 2,193 | $257,499 | $83 |
| Ultrasound of both sides of head and neck blood flow | 794 | $126,101 | $158 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 1,738 | $110,528 | $63 |
| Short return visit (20+ min) | 1,226 | $69,158 | $53 |
| New patient visit (30+ min) | 860 | $65,097 | $76 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 257 | $55,674 | $217 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 1,911 | $26,208 | $13 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 303 | $20,619 | $67 |
| Programming of dual lead pacemaker system | 182 | $16,164 | $42 |
| Ultrasound of heart blood flow, valves and chambers | 257 | $11,664 | $45 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 50 | $10,557 | $211 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 12 | $6,051 | $432 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system | 108 | $5,780 | $27 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 34 | $5,652 | $166 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 257 | $5,554 | $22 |
| Programming of single lead pacemaker system | 54 | $3,942 | $38 |
| Programming of dual lead implantable defibrillator system | 28 | $3,359 | $60 |
| Programming of multiple lead implantable defibrillator system | 22 | $3,007 | $67 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system | 32 | $2,751 | $48 |
| Ultrasound study of arm and leg arteries | 34 | $2,442 | $72 |
| Injection for imaging of aorta above heart valve with review by radiologist | 55 | $2,279 | $41 |
| Implantation patient-activated heart monitoring device | 12 | $1,874 | $156 |
| Evaluation of implantable heart and blood vessel monitoring system | 42 | $1,771 | $24 |
| Evaluation of cardiac rhythm monitor system | 19 | $1,567 | $30 |
| Ambulatory blood pressure monitoring, 1 day or longer, with recording, scanning analysis, interpretation, and report | 32 | $1,249 | $39 |
| Programming of single lead implantable defibrillator system | 11 | $1,219 | $45 |
| Programming of cardiac rhythm monitor system | 21 | $1,021 | $26 |
| New patient visit (10+ min) | 26 | $843 | $32 |
| Electrocardiogram (ecg) 2-day continuous with report | 12 | $356 | $30 |
| Injection, aminophyllin, up to 250 mg | 40 | $267 | None |
| Programming of single, dual, or multiple lead or leadless pacemaker system before or after surgery | 16 | $199 | $12 |
| Electrocardiogram (ecg) 2-day continuous | 11 | $153 | $14 |
2016: 32 services
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 1,717 | $688,330 | $399 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 1,984 | $356,091 | $176 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 1,717 | $327,409 | $95 |
| Injection, regadenoson, 0.1 mg | 1,657 | $279,123 | None |
| Return visit (30+ min) | 1,781 | $198,748 | $83 |
| Ultrasound of both sides of head and neck blood flow | 776 | $119,161 | $153 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 1,720 | $109,713 | $63 |
| Short return visit (20+ min) | 1,326 | $79,671 | $56 |
| New patient visit (30+ min) | 739 | $55,576 | $75 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 166 | $37,053 | $223 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 1,852 | $25,659 | $13 |
| Programming of dual lead pacemaker system | 183 | $16,613 | $41 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 66 | $15,095 | $225 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 189 | $12,558 | $66 |
| Ultrasound of heart blood flow, valves and chambers | 166 | $7,603 | $46 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 49 | $7,545 | $154 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 13 | $6,504 | $434 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system | 101 | $5,261 | $28 |
| Programming of multiple lead implantable defibrillator system | 31 | $3,714 | $63 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 166 | $3,615 | $22 |
| Programming of single lead pacemaker system | 54 | $3,531 | $36 |
| Programming of dual lead implantable defibrillator system | 28 | $3,429 | $60 |
| Injection for imaging of aorta above heart valve with review by radiologist | 74 | $3,107 | $41 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system | 35 | $2,878 | $45 |
| Ultrasound study of arm and leg arteries | 30 | $2,189 | $73 |
| Implantation patient-activated heart monitoring device | 11 | $1,750 | $159 |
| Ambulatory blood pressure monitoring, 1 day or longer, with recording, scanning analysis, interpretation, and report | 36 | $1,381 | $38 |
| New patient visit (45+ min) | 12 | $1,375 | $115 |
| Evaluation of implantable heart and blood vessel monitoring system | 26 | $1,029 | $24 |
| Short return visit | 14 | $497 | $35 |
| Programming of single, dual, or multiple lead or leadless pacemaker system before or after surgery | 20 | $250 | $12 |
| Injection, aminophyllin, up to 250 mg | 27 | $170 | None |
2015: 36 services
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 1,423 | $573,288 | $402 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 1,938 | $355,588 | $181 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 1,419 | $330,147 | $116 |
| Injection, regadenoson, 0.1 mg | 1,358 | $223,841 | None |
| Return visit (30+ min) | 1,240 | $140,125 | $85 |
| Short return visit (20+ min) | 1,648 | $103,189 | $56 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 1,418 | $87,059 | $61 |
| Ultrasound of both sides of head and neck blood flow | 488 | $75,910 | $155 |
| New patient visit (30+ min) | 638 | $51,202 | $80 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 178 | $38,757 | $218 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 1,764 | $25,676 | $13 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 75 | $16,547 | $218 |
| Programming of dual lead pacemaker system | 165 | $15,110 | $43 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 144 | $10,111 | $67 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 18 | $9,644 | $438 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 51 | $8,408 | $165 |
| Ultrasound of heart blood flow, valves and chambers | 174 | $7,951 | $46 |
| New patient visit (45+ min) | 59 | $7,202 | $122 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system | 115 | $5,697 | $27 |
| Programming of multiple lead implantable defibrillator system | 29 | $4,214 | $68 |
| Insertion of tube in right and left heart chambers and coronary artery for diagnosis with review by radiologist | 14 | $3,998 | $286 |
| Programming of single lead pacemaker system | 54 | $3,914 | $38 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 174 | $3,834 | $22 |
| Injection for imaging of aorta above heart valve with review by radiologist | 89 | $3,735 | $41 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system | 43 | $3,624 | $48 |
| Programming of dual lead implantable defibrillator system | 31 | $3,340 | $59 |
| Short return visit | 100 | $3,064 | $30 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 12 | $1,835 | $153 |
| Ultrasound study of arm and leg arteries | 21 | $1,514 | $72 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 90 | $1,489 | $17 |
| External shock to heart to regulate heart beat | 12 | $1,296 | $100 |
| Programming of single lead implantable defibrillator system | 14 | $1,026 | $47 |
| Ambulatory blood pressure monitoring, 1 day or longer, with recording, scanning analysis, interpretation, and report | 20 | $882 | $42 |
| Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days | 12 | $692 | $17 |
| Evaluation of implantable heart and blood vessel monitoring system | 22 | $691 | $24 |
| Injection, aminophyllin, up to 250 mg | 41 | $208 | None |
2014: 32 services
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 1,362 | $545,152 | $398 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 1,358 | $317,194 | $117 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 1,699 | $309,572 | $178 |
| Injection, regadenoson, 0.1 mg | 1,299 | $214,885 | None |
| Short return visit (20+ min) | 1,929 | $147,585 | $57 |
| Ultrasound of both sides of head and neck blood flow | 577 | $82,679 | $143 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 1,302 | $71,568 | $55 |
| Return visit (30+ min) | 529 | $52,145 | $85 |
| New patient visit (30+ min) | 567 | $44,715 | $79 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 147 | $32,687 | $222 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 1,630 | $23,794 | $13 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 61 | $14,001 | $230 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 183 | $12,827 | $69 |
| Programming of dual lead pacemaker system | 128 | $10,969 | $44 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system | 133 | $7,587 | $27 |
| Ultrasound of heart blood flow, valves and chambers | 148 | $6,680 | $45 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 12 | $6,179 | $441 |
| Short return visit | 191 | $6,011 | $31 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 36 | $5,450 | $151 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system | 53 | $4,590 | $45 |
| Programming of multiple lead implantable defibrillator system | 25 | $3,552 | $67 |
| New patient visit (45+ min) | 27 | $3,291 | $122 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 148 | $3,216 | $22 |
| Injection for imaging of aorta above heart valve with review by radiologist | 78 | $3,132 | $40 |
| Programming of single lead pacemaker system | 41 | $3,106 | $39 |
| Ultrasound study of arm and leg arteries | 35 | $2,405 | $67 |
| Programming of dual lead implantable defibrillator system | 21 | $2,140 | $55 |
| Ambulatory blood pressure monitoring, 1 day or longer, with recording, scanning analysis, interpretation, and report | 19 | $803 | $42 |
| Evaluation of implantable heart and blood vessel monitoring system | 15 | $322 | $21 |
| Electrocardiogram (ecg) 1 to 3 leads with review by physician | 32 | $307 | $9 |
| Programming of single, dual, or multiple lead or leadless pacemaker system before or after surgery | 12 | $237 | $12 |
| Injection, aminophyllin, up to 250 mg | 69 | $130 | None |
2013: 36 services
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 1,418 | $590,388 | $413 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 1,441 | $338,085 | $117 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 1,686 | $248,708 | $145 |
| Injection, regadenoson, 0.1 mg | 1,362 | $229,572 | None |
| Short return visit (20+ min) | 1,755 | $137,370 | $57 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 1,432 | $82,323 | $57 |
| Ultrasound of both sides of head and neck blood flow | 490 | $73,651 | $149 |
| New patient visit (30+ min) | 461 | $36,369 | $79 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 206 | $35,196 | $171 |
| Return visit (30+ min) | 406 | $33,072 | $74 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 1,508 | $23,532 | $14 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 186 | $13,875 | $72 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 64 | $13,390 | $209 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 22 | $10,793 | $432 |
| Ultrasound of heart blood flow, valves and chambers | 212 | $7,864 | $37 |
| Programming of dual lead pacemaker system | 109 | $6,856 | $42 |
| Short return visit | 193 | $6,621 | $34 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 34 | $5,232 | $154 |
| Insertion of pacemaker and upper and lower heart chamber electrode | 12 | $4,516 | $376 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system | 110 | $4,228 | $27 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 212 | $3,525 | $17 |
| Insertion of tube in left lower heart chamber, coronary artery and bypass graft for diagnosis with review by radiologist | 15 | $3,397 | $212 |
| Programming of multiple lead implantable defibrillator system | 27 | $3,324 | $68 |
| Injection for imaging of aorta above heart valve with review by radiologist | 83 | $3,181 | $38 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system | 42 | $2,969 | $43 |
| Programming of dual lead implantable defibrillator system | 25 | $2,608 | $58 |
| Programming of single lead pacemaker system | 41 | $2,341 | $38 |
| Electrocardiogram (ecg) up to 30 days continuous with symptom monitoring and review and report by health care professional | 13 | $2,303 | $177 |
| Ultrasound study of arm and leg arteries | 20 | $1,502 | $75 |
| Ambulatory blood pressure monitoring, 1 day or longer, with recording, scanning analysis, interpretation, and report | 22 | $948 | $43 |
| New patient visit (15+ min) | 15 | $922 | $61 |
| Evaluation of implantable heart and blood vessel monitoring system | 14 | $507 | $23 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 62 | $490 | $6 |
| Electrocardiogram (ecg) 1 to 3 leads with review by physician | 32 | $368 | $11 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 12 | $203 | $17 |
| Injection, aminophyllin, up to 250 mg | 42 | $35 | None |
Medicaid work
$71,726 in 2024
Medicaid paid $71,726 for 9,781 billed services this clinician did in 2024, up to 210 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 1,160 | $15,450 |
| External mobile cardiovascular telemetry with electrocardiographic recording, concurrent computerized real time data analysis and greater than 24 hours of accessible ECG data storage (retrievable with query) with ECG triggered and patient selected events transmitted to a remote attended surveillance center for up to 30 days; technical support for connection and patient instructions for use, attended surveillance, analysis and transmission of daily and emergent data reports as prescribed by a physician or other qualified health care professional | 503 | $13,589 |
| Return visit (30+ min) | 1,676 | $8,992 |
| Myocardial perfusion imaging, tomographic (SPECT) (including attenuation correction, qualitative or quantitative wall motion, ejection fraction by first pass or gated technique, additional quantification, when performed); multiple studies, at rest and/or stress (exercise or pharmacologic) and/or redistribution and/or rest reinjection | 514 | $6,569 |
| Injection, regadenoson, 0.1 mg | 420 | $4,129 |
| New patient visit (30+ min) | 389 | $3,758 |
| CARDIOVASCULAR STRESS TEST | 761 | $3,714 |
| Tc99m sestamibi | 526 | $3,607 |
| New patient visit (45+ min) | 354 | $3,170 |
| Electrocardiogram, routine ECG with at least 12 leads; with interpretation and report | 1,642 | $2,793 |
| XTRNL ECG REC<48 HRS RECORDING SCAN A/R R&I | 540 | $2,076 |
| DUPLEX SCAN EXTRACRANIAL ART COMPL BI STUDY | 354 | $1,960 |
| 2024 | 9,781 | 17 | 210 | $71,726 |
| 2023 | 12,207 | 23 | 214 | $63,391 |
| 2022 | 9,842 | 20 | 230 | $38,059 |
| 2021 | 5,108 | 18 | 91 | $29,270 |
| 2020 | 6,993 | 19 | 104 | $19,130 |
| 2019 | 4,131 | 16 | 114 | $14,979 |
| 2018 | 5,723 | 16 | 91 | $33,228 |
See the largest Medicaid services in earlier years
2023
| External mobile cardiovascular telemetry with electrocardiographic recording, concurrent computerized real time data analysis and greater than 24 hours of accessible ECG data storage (retrievable with query) with ECG triggered and patient selected events transmitted to a remote attended surveillance center for up to 30 days; technical support for connection and patient instructions for use, attended surveillance, analysis and transmission of daily and emergent data reports as prescribed by a physician or other qualified health care professional | 702 | $16,705 |
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 1,309 | $13,698 |
| Injection, regadenoson, 0.1 mg | 459 | $4,087 |
| New patient visit (30+ min) | 580 | $3,573 |
| XTRNL ECG REC<48 HRS RECORDING SCAN A/R R&I | 723 | $3,348 |
| DUPLEX SCAN EXTRACRANIAL ART COMPL BI STUDY | 512 | $2,969 |
| Myocardial perfusion imaging, tomographic (SPECT) (including attenuation correction, qualitative or quantitative wall motion, ejection fraction by first pass or gated technique, additional quantification, when performed); multiple studies, at rest and/or stress (exercise or pharmacologic) and/or redistribution and/or rest reinjection | 638 | $2,953 |
| CARDIOVASCULAR STRESS TEST | 892 | $2,735 |
| Tc99m sestamibi | 628 | $2,678 |
| Electrocardiogram, routine ECG with at least 12 leads; with interpretation and report | 1,926 | $2,341 |
| Return visit (30+ min) | 1,033 | $2,070 |
| Short return visit (20+ min) | 961 | $1,984 |
2022
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 1,074 | $7,169 |
| External mobile cardiovascular telemetry with electrocardiographic recording, concurrent computerized real time data analysis and greater than 24 hours of accessible ECG data storage (retrievable with query) with ECG triggered and patient selected events transmitted to a remote attended surveillance center for up to 30 days; technical support for connection and patient instructions for use, attended surveillance, analysis and transmission of daily and emergent data reports as prescribed by a physician or other qualified health care professional | 412 | $5,467 |
| Myocardial perfusion imaging, tomographic (SPECT) (including attenuation correction, qualitative or quantitative wall motion, ejection fraction by first pass or gated technique, additional quantification, when performed); multiple studies, at rest and/or stress (exercise or pharmacologic) and/or redistribution and/or rest reinjection | 542 | $4,455 |
| Injection, regadenoson, 0.1 mg | 453 | $4,208 |
| New patient visit (30+ min) | 653 | $2,746 |
| Tc99m sestamibi | 535 | $2,480 |
| CARDIOVASCULAR STRESS TEST | 766 | $2,103 |
| Return visit (30+ min) | 745 | $1,735 |
| Electrocardiogram, routine ECG with at least 12 leads; with interpretation and report | 1,776 | $1,585 |
| XTRNL ECG REC<48 HRS RECORDING SCAN A/R R&I | 519 | $1,467 |
| DUPLEX SCAN EXTRACRANIAL ART COMPL BI STUDY | 384 | $1,463 |
| XTRNL MOBILE CV TELEMETRY W/I&REPORT 30 DAYS | 416 | $906 |
2021
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 623 | $7,925 |
| External mobile cardiovascular telemetry with electrocardiographic recording, concurrent computerized real time data analysis and greater than 24 hours of accessible ECG data storage (retrievable with query) with ECG triggered and patient selected events transmitted to a remote attended surveillance center for up to 30 days; technical support for connection and patient instructions for use, attended surveillance, analysis and transmission of daily and emergent data reports as prescribed by a physician or other qualified health care professional | 171 | $4,252 |
| Myocardial perfusion imaging, tomographic (SPECT) (including attenuation correction, qualitative or quantitative wall motion, ejection fraction by first pass or gated technique, additional quantification, when performed); multiple studies, at rest and/or stress (exercise or pharmacologic) and/or redistribution and/or rest reinjection | 306 | $2,432 |
| Return visit (30+ min) | 429 | $1,917 |
| Injection, regadenoson, 0.1 mg | 320 | $1,867 |
| New patient visit (30+ min) | 116 | $1,717 |
| DUPLEX SCAN EXTRACRANIAL ART COMPL BI STUDY | 244 | $1,679 |
| XTRNL MOBILE CV TELEMETRY W/I&REPORT 30 DAYS | 171 | $1,668 |
| Short return visit (20+ min) | 547 | $1,591 |
| XTRNL ECG REC<48 HRS RECORDING SCAN A/R R&I | 207 | $1,041 |
| Electrocardiogram, routine ECG with at least 12 leads; with interpretation and report | 914 | $1,025 |
| Tc99m sestamibi | 343 | $1,017 |
2020
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 861 | $5,373 |
| XTRNL ECG REC<48 HRS RECORDING SCAN A/R R&I | 309 | $1,633 |
| Injection, regadenoson, 0.1 mg | 325 | $1,544 |
| New patient visit (30+ min) | 464 | $1,527 |
| CARDIOVASCULAR STRESS TEST | 560 | $1,447 |
| Return visit (30+ min) | 642 | $1,284 |
| External mobile cardiovascular telemetry with electrocardiographic recording, concurrent computerized real time data analysis and greater than 24 hours of accessible ECG data storage (retrievable with query) with ECG triggered and patient selected events transmitted to a remote attended surveillance center for up to 30 days; technical support for connection and patient instructions for use, attended surveillance, analysis and transmission of daily and emergent data reports as prescribed by a physician or other qualified health care professional | 219 | $1,282 |
| Myocardial perfusion imaging, tomographic (SPECT) (including attenuation correction, qualitative or quantitative wall motion, ejection fraction by first pass or gated technique, additional quantification, when performed); multiple studies, at rest and/or stress (exercise or pharmacologic) and/or redistribution and/or rest reinjection | 448 | $1,097 |
| Electrocardiogram, routine ECG with at least 12 leads; with interpretation and report | 1,078 | $932 |
| Tc99m sestamibi | 458 | $720 |
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, during rest and cardiovascular stress test using treadmill, bicycle exercise and/or pharmacologically induced stress, with interpretation and report; including performance of continuous electrocardiographic monitoring, with supervision by a physician or other qualified health care professional | 145 | $581 |
| DUPLEX SCAN EXTRACRANIAL ART COMPL BI STUDY | 281 | $573 |
2019
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 625 | $3,333 |
| Myocardial perfusion imaging, tomographic (SPECT) (including attenuation correction, qualitative or quantitative wall motion, ejection fraction by first pass or gated technique, additional quantification, when performed); multiple studies, at rest and/or stress (exercise or pharmacologic) and/or redistribution and/or rest reinjection | 314 | $3,053 |
| Injection, regadenoson, 0.1 mg | 253 | $2,287 |
| Tc99m sestamibi | 336 | $1,275 |
| CARDIOVASCULAR STRESS TEST | 362 | $1,176 |
| Return visit (30+ min) | 474 | $973 |
| Electrocardiogram, routine ECG with at least 12 leads; with interpretation and report | 803 | $679 |
| New patient visit (30+ min) | 164 | $668 |
| OFFICE/OP CONSLTJ NEW/EST PT LOW MDM 30 MINUTES | 292 | $482 |
| Short return visit (20+ min) | 228 | $471 |
| DUPLEX SCAN EXTRACRANIAL ART COMPL BI STUDY | 86 | $304 |
| XTRNL ECG REC<48 HRS RECORDING SCAN A/R R&I | 87 | $266 |
2018
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 963 | $6,376 |
| Myocardial perfusion imaging, tomographic (SPECT) (including attenuation correction, qualitative or quantitative wall motion, ejection fraction by first pass or gated technique, additional quantification, when performed); multiple studies, at rest and/or stress (exercise or pharmacologic) and/or redistribution and/or rest reinjection | 466 | $6,048 |
| Injection, regadenoson, 0.1 mg | 396 | $4,994 |
| Tc99m sestamibi | 478 | $3,004 |
| OFFICE/OP CONSLTJ NEW/EST PT LOW MDM 30 MINUTES | 268 | $2,517 |
| CARDIOVASCULAR STRESS TEST | 573 | $2,200 |
| Electrocardiogram, routine ECG with at least 12 leads; with interpretation and report | 918 | $2,128 |
| Return visit (30+ min) | 582 | $1,841 |
| New patient visit (30+ min) | 115 | $961 |
| DUPLEX SCAN EXTRACRANIAL ART COMPL BI STUDY | 177 | $902 |
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, during rest and cardiovascular stress test using treadmill, bicycle exercise and/or pharmacologically induced stress, with interpretation and report; including performance of continuous electrocardiographic monitoring, with supervision by a physician or other qualified health care professional | 27 | $795 |
| XTRNL ECG REC<48 HRS RECORDING SCAN A/R R&I | 117 | $683 |
Drugs they prescribed that Part D paid
$2,856,218
Pharmacies billed $2,856,218 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 8,963) in 2024. At or below the middle of the specialty; the typical cardiology clinician is at 0%.
6,507 generic and 2,456 brand-name prescriptions · $2,856,218 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Eliquis | 905 | $1,062,956 | $1,175 |
| Entresto | 362 | $393,835 | $1,088 |
| Xarelto | 272 | $329,098 | $1,210 |
| Repatha Sureclick | 302 | $321,514 | $1,065 |
| Jardiance | 237 | $242,825 | $1,025 |
See all 65 drugs
| Eliquis | 905 | $1,062,956 | $1,175 |
| Entresto | 362 | $393,835 | $1,088 |
| Xarelto | 272 | $329,098 | $1,210 |
| Repatha Sureclick | 302 | $321,514 | $1,065 |
| Jardiance | 237 | $242,825 | $1,025 |
| Farxiga | 60 | $70,556 | $1,176 |
| Ozempic | 19 | $27,991 | $1,473 |
| Brilinta | 20 | $18,176 | $909 |
| Metoprolol | 1,037 | $16,797 | $16 |
| Edarbi | 44 | $14,191 | $323 |
| Valsartan | 185 | $6,619 | $36 |
| Dabigatran Etexilate | 31 | $6,210 | $200 |
| Irbesartan | 243 | $5,429 | $22 |
| Ranolazine Er | 35 | $5,294 | $151 |
| Olmesartan-Hydrochlorothiazide | 92 | $4,683 | $51 |
| Atorvastatin | 444 | $4,547 | $10 |
| Rosuvastatin | 211 | $4,215 | $20 |
| Olmesartan Medoxomil | 177 | $4,183 | $24 |
| Amlodipine Besylate | 644 | $3,979 | $6 |
| Losartan | 263 | $2,980 | $11 |
| Spironolactone | 317 | $2,931 | $9 |
| Clopidogrel | 207 | $2,787 | $13 |
| Icosapent Ethyl | 18 | $2,737 | $152 |
| Amiodarone | 44 | $2,709 | $62 |
| Carvedilol | 322 | $2,547 | $8 |
| Nebivolol | 33 | $2,274 | $69 |
| Potassium Chloride | 86 | $2,136 | $25 |
| Torsemide | 112 | $2,044 | $18 |
| Amlodipine-Valsartan | 25 | $1,733 | $69 |
| Nitroglycerin | 165 | $1,609 | $10 |
| Metolazone | 33 | $1,568 | $48 |
| Digoxin | 54 | $1,456 | $27 |
| Metoprolol | 213 | $1,371 | $6 |
| Irbesartan-Hydrochlorothiazide | 41 | $1,353 | $33 |
| Ezetimibe | 51 | $1,341 | $26 |
| Doxazosin Mesylate | 96 | $1,310 | $14 |
| Valsartan-Hydrochlorothiazide | 46 | $1,226 | $27 |
| Isosorbide Mononitrate Er | 62 | $1,220 | $20 |
| Bumetanide | 41 | $1,147 | $28 |
| Diltiazem 24hr Er (Cd) | 29 | $1,144 | $39 |
| Fenofibrate | 14 | $1,119 | $80 |
| Furosemide | 209 | $1,068 | $5 |
| Hydralazine | 81 | $1,049 | $13 |
| Lisinopril | 171 | $1,042 | $6 |
| Flecainide Acetate | 23 | $932 | $41 |
| Isosorbide Dinitrate | 16 | $920 | $58 |
| Nifedipine Er | 14 | $836 | $60 |
| Hydrochlorothiazide | 147 | $827 | $6 |
| Chlorthalidone | 38 | $736 | $19 |
| Midodrine | 24 | $677 | $28 |
| Telmisartan | 14 | $641 | $46 |
| Losartan-Hydrochlorothiazide | 38 | $566 | $15 |
| Atenolol | 73 | $512 | $7 |
| Verapamil Er | 14 | $495 | $35 |
| Propafenone | 13 | $431 | $33 |
| Fludrocortisone Acetate | 12 | $388 | $32 |
| Simvastatin | 25 | $260 | $10 |
| Pravastatin | 26 | $222 | $9 |
| Benazepril | 15 | $218 | $15 |
| Sotalol | 12 | $216 | $18 |
| Verapamil | 11 | $211 | $19 |
| Klor-Con 8 | 15 | $192 | $13 |
| Lovastatin | 14 | $145 | $10 |
| Bisoprolol | 11 | $135 | $12 |
| Ramipril | 20 | $118 | $6 |
Year by year
| 2024 | 8,963 | 1,561 | 0% (0) | 27% | $2,856,218 |
| 2023 | 7,890 | 1,392 | 0% (0) | 25% | $2,298,000 |
| 2022 | 8,465 | 1,415 | 0% (0) | 26% | $2,214,498 |
| 2021 | 8,970 | 1,454 | 0% (0) | 27% | $1,984,726 |
| 2020 | 9,184 | 1,485 | 0% (0) | 26% | $1,719,220 |
| 2019 | 8,914 | 1,557 | 0% (0) | 23% | $1,391,522 |
| 2018 | 9,111 | 1,512 | 0% (0) | 22% | $1,081,900 |
| 2017 | 9,318 | 1,404 | 0% (0) | 30% | $989,863 |
| 2016 | 8,064 | 1,257 | 0% (0) | None | $827,955 |
| 2015 | 7,507 | 1,138 | 0% (0) | None | $639,283 |
| 2014 | 6,704 | 1,038 | 0% (0) | 33% | $496,680 |
| 2013 | 6,335 | 921 | None | None | $438,335 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 72 drugs
| Eliquis | 884 | $1,032,534 | $1,168 |
| Xarelto | 310 | $381,708 | $1,231 |
| Entresto | 192 | $248,902 | $1,296 |
| Repatha Sureclick | 179 | $197,378 | $1,103 |
| Jardiance | 56 | $82,262 | $1,469 |
| Farxiga | 21 | $38,029 | $1,811 |
| Edarbi | 63 | $23,562 | $374 |
| Metoprolol | 916 | $21,147 | $23 |
| Brilinta | 17 | $20,989 | $1,235 |
| Droxidopa | 18 | $15,389 | $855 |
| Pradaxa | 24 | $13,336 | $556 |
| Edarbyclor | 29 | $13,090 | $451 |
| Dabigatran Etexilate | 22 | $11,180 | $508 |
| Vascepa | 18 | $10,309 | $573 |
| Irbesartan | 279 | $9,717 | $35 |
| Ranolazine Er | 42 | $9,715 | $231 |
| Valsartan | 116 | $7,408 | $64 |
| Isosorbide Dinitrate | 25 | $7,333 | $293 |
| Olmesartan Medoxomil | 181 | $7,216 | $40 |
| Olmesartan-Hydrochlorothiazide | 94 | $7,092 | $75 |
| Potassium Chloride | 125 | $7,086 | $57 |
| Icosapent Ethyl | 12 | $6,267 | $522 |
| Amlodipine Besylate | 501 | $6,131 | $12 |
| Atorvastatin | 336 | $5,726 | $17 |
| Amiodarone | 48 | $4,250 | $89 |
| Carvedilol | 283 | $3,950 | $14 |
| Losartan | 225 | $3,846 | $17 |
| Clopidogrel | 232 | $3,802 | $16 |
| Spironolactone | 211 | $3,605 | $17 |
| Torsemide | 138 | $3,009 | $22 |
| Irbesartan-Hydrochlorothiazide | 71 | $2,926 | $41 |
| Metoprolol | 233 | $2,851 | $12 |
| Nitroglycerin | 208 | $2,836 | $14 |
| Lisinopril | 211 | $2,611 | $12 |
| Valsartan-Hydrochlorothiazide | 42 | $2,503 | $60 |
| Doxazosin Mesylate | 101 | $2,466 | $24 |
| Digoxin | 70 | $2,320 | $33 |
| Rosuvastatin | 45 | $2,051 | $46 |
| Furosemide | 226 | $2,030 | $9 |
| Amlodipine-Valsartan | 16 | $1,743 | $109 |
| Bumetanide | 41 | $1,724 | $42 |
| Flecainide Acetate | 27 | $1,707 | $63 |
| Isosorbide Mononitrate Er | 51 | $1,644 | $32 |
| Ezetimibe | 22 | $1,643 | $75 |
| Prasugrel | 20 | $1,570 | $78 |
| Diltiazem 24hr Er (Cd) | 28 | $1,394 | $50 |
| Hydralazine | 59 | $1,328 | $23 |
| Potassium Citrate Er | 11 | $1,221 | $111 |
| Nebivolol | 17 | $1,183 | $70 |
| Metolazone | 18 | $1,093 | $61 |
| Telmisartan | 24 | $1,033 | $43 |
| Nifedipine Er | 15 | $899 | $60 |
| Losartan-Hydrochlorothiazide | 31 | $845 | $27 |
| Chlorthalidone | 29 | $764 | $26 |
| Verapamil Er | 19 | $759 | $40 |
| Fenofibrate | 17 | $759 | $45 |
| Benazepril | 31 | $724 | $23 |
| Amlodipine Besylate-Benazepril | 16 | $698 | $44 |
| Hydrochlorothiazide | 123 | $691 | $6 |
| Propafenone | 23 | $686 | $30 |
| Atenolol | 55 | $658 | $12 |
| Sotalol | 11 | $642 | $58 |
| Fludrocortisone Acetate | 21 | $629 | $30 |
| Fenofibrate | 11 | $589 | $54 |
| Pravastatin | 25 | $524 | $21 |
| Klor-Con 8 | 12 | $462 | $39 |
| Simvastatin | 31 | $442 | $14 |
| Verapamil | 13 | $345 | $27 |
| Enalapril Maleate | 14 | $206 | $15 |
| Lovastatin | 13 | $204 | $16 |
| Bisoprolol | 11 | $184 | $17 |
| Ramipril | 25 | $183 | $7 |
2022: 71 drugs
| Eliquis | 970 | $1,008,473 | $1,040 |
| Xarelto | 385 | $447,304 | $1,162 |
| Entresto | 212 | $215,763 | $1,018 |
| Repatha Sureclick | 124 | $132,423 | $1,068 |
| Pradaxa | 64 | $66,933 | $1,046 |
| Brilinta | 36 | $35,045 | $973 |
| Jardiance | 25 | $32,053 | $1,282 |
| Edarbi | 66 | $27,084 | $410 |
| Metoprolol | 932 | $20,064 | $22 |
| Edarbyclor | 42 | $18,783 | $447 |
| Vascepa | 21 | $10,720 | $510 |
| Irbesartan | 262 | $9,496 | $36 |
| Ranolazine Er | 46 | $9,467 | $206 |
| Potassium Chloride | 184 | $9,050 | $49 |
| Isosorbide Dinitrate | 29 | $6,334 | $218 |
| Olmesartan Medoxomil | 170 | $6,027 | $35 |
| Olmesartan-Hydrochlorothiazide | 72 | $5,295 | $74 |
| Valsartan | 82 | $5,263 | $64 |
| Atorvastatin | 324 | $5,039 | $16 |
| Prasugrel | 28 | $4,546 | $162 |
| Clopidogrel | 262 | $4,437 | $17 |
| Zontivity | 11 | $4,363 | $397 |
| Amiodarone | 76 | $4,298 | $57 |
| Propafenone Hcl Er | 20 | $4,234 | $212 |
| Carvedilol | 336 | $4,197 | $12 |
| Nitroglycerin | 255 | $4,093 | $16 |
| Amlodipine Besylate | 528 | $3,837 | $7 |
| Flecainide Acetate | 49 | $3,770 | $77 |
| Losartan | 226 | $3,200 | $14 |
| Digoxin | 86 | $3,131 | $36 |
| Bumetanide | 50 | $3,044 | $61 |
| Irbesartan-Hydrochlorothiazide | 84 | $2,907 | $35 |
| Spironolactone | 203 | $2,657 | $13 |
| Torsemide | 157 | $2,483 | $16 |
| Metoprolol | 277 | $2,475 | $9 |
| Carvedilol Er | 13 | $2,425 | $187 |
| Doxazosin Mesylate | 114 | $2,348 | $21 |
| Metolazone | 41 | $2,176 | $53 |
| Nebivolol | 17 | $2,064 | $121 |
| Valsartan-Hydrochlorothiazide | 26 | $1,951 | $75 |
| Furosemide | 268 | $1,741 | $6 |
| Isosorbide Mononitrate Er | 67 | $1,670 | $25 |
| Chlorthalidone | 48 | $1,667 | $35 |
| Propafenone | 31 | $1,598 | $52 |
| Lisinopril | 168 | $1,592 | $9 |
| Rosuvastatin | 50 | $1,565 | $31 |
| Diltiazem 24hr Er (Cd) | 35 | $1,540 | $44 |
| Ezetimibe | 20 | $1,512 | $76 |
| Verapamil Er | 35 | $1,304 | $37 |
| Nifedipine Er | 12 | $1,274 | $106 |
| Telmisartan | 23 | $1,237 | $54 |
| Amlodipine-Valsartan | 13 | $1,225 | $94 |
| Hydralazine | 62 | $1,177 | $19 |
| Hydrochlorothiazide | 163 | $844 | $5 |
| Fenofibrate | 12 | $759 | $63 |
| Atenolol | 65 | $613 | $9 |
| Sotalol | 14 | $500 | $36 |
| Simvastatin | 40 | $431 | $11 |
| Losartan-Hydrochlorothiazide | 14 | $387 | $28 |
| Klor-Con 10 | 12 | $376 | $31 |
| Amlodipine Besylate-Benazepril | 11 | $347 | $32 |
| Benazepril | 23 | $342 | $15 |
| Fludrocortisone Acetate | 17 | $342 | $20 |
| Clonidine | 19 | $340 | $18 |
| Ramipril | 25 | $332 | $13 |
| Bisoprolol | 13 | $311 | $24 |
| Enalapril Maleate | 18 | $307 | $17 |
| Lovastatin | 11 | $275 | $25 |
| Pravastatin | 12 | $262 | $22 |
| Lisinopril-Hydrochlorothiazide | 16 | $244 | $15 |
| Klor-Con 8 | 12 | $210 | $18 |
2021: 72 drugs
| Eliquis | 916 | $868,106 | $948 |
| Xarelto | 381 | $385,170 | $1,011 |
| Entresto | 219 | $200,191 | $914 |
| Pradaxa | 82 | $82,360 | $1,004 |
| Repatha Sureclick | 112 | $75,503 | $674 |
| Brilinta | 49 | $34,090 | $696 |
| Edarbyclor | 66 | $28,588 | $433 |
| Metoprolol | 902 | $22,590 | $25 |
| Corlanor | 18 | $17,230 | $957 |
| Edarbi | 54 | $15,367 | $285 |
| Bystolic | 27 | $14,348 | $531 |
| Ranolazine Er | 55 | $13,058 | $237 |
| Vascepa | 26 | $12,946 | $498 |
| Irbesartan | 290 | $12,666 | $44 |
| Potassium Chloride | 254 | $11,558 | $46 |
| Zontivity | 22 | $8,196 | $373 |
| Amiodarone | 87 | $7,225 | $83 |
| Olmesartan Medoxomil | 125 | $6,563 | $53 |
| Valsartan | 79 | $5,925 | $75 |
| Atorvastatin | 341 | $5,528 | $16 |
| Clopidogrel | 317 | $5,200 | $16 |
| Carvedilol | 419 | $5,172 | $12 |
| Propafenone Hcl Er | 17 | $4,651 | $274 |
| Flecainide Acetate | 81 | $4,409 | $54 |
| Nitroglycerin | 251 | $4,314 | $17 |
| Digoxin | 113 | $4,249 | $38 |
| Amlodipine Besylate | 540 | $4,227 | $8 |
| Bumetanide | 38 | $3,788 | $100 |
| Irbesartan-Hydrochlorothiazide | 88 | $3,614 | $41 |
| Metolazone | 73 | $3,580 | $49 |
| Chlorthalidone | 78 | $3,352 | $43 |
| Prasugrel | 41 | $3,239 | $79 |
| Olmesartan-Hydrochlorothiazide | 43 | $3,219 | $75 |
| Torsemide | 182 | $3,077 | $17 |
| Doxazosin Mesylate | 115 | $3,061 | $27 |
| Losartan | 215 | $2,942 | $14 |
| Metoprolol | 290 | $2,942 | $10 |
| Isosorbide Dinitrate | 31 | $2,860 | $92 |
| Carvedilol Er | 16 | $2,567 | $160 |
| Pacerone | 19 | $2,562 | $135 |
| Diltiazem 24hr Er (Cd) | 39 | $2,517 | $65 |
| Amlodipine-Valsartan | 25 | $2,507 | $100 |
| Isosorbide Mononitrate Er | 73 | $2,378 | $33 |
| Rosuvastatin | 53 | $2,370 | $45 |
| Verapamil Er | 45 | $2,180 | $48 |
| Valsartan-Hydrochlorothiazide | 32 | $1,894 | $59 |
| Telmisartan | 20 | $1,820 | $91 |
| Furosemide | 302 | $1,806 | $6 |
| Ezetimibe | 18 | $1,584 | $88 |
| Lisinopril | 198 | $1,476 | $7 |
| Hydralazine | 95 | $1,391 | $15 |
| Spironolactone | 129 | $1,377 | $11 |
| Nifedipine Er | 16 | $1,083 | $68 |
| Propafenone | 19 | $1,040 | $55 |
| Diltiazem 24hr Er | 16 | $1,012 | $63 |
| Klor-Con 10 | 24 | $962 | $40 |
| Propranolol | 16 | $951 | $59 |
| Hydrochlorothiazide | 168 | $902 | $5 |
| Fenofibrate | 11 | $886 | $81 |
| Atenolol | 87 | $782 | $9 |
| Sotalol | 14 | $536 | $38 |
| Amlodipine Besylate-Benazepril | 12 | $524 | $44 |
| Enalapril Maleate | 18 | $488 | $27 |
| Simvastatin | 59 | $461 | $8 |
| Pravastatin | 23 | $437 | $19 |
| Benazepril | 34 | $377 | $11 |
| Ramipril | 36 | $372 | $10 |
| Bisoprolol | 14 | $351 | $25 |
| Losartan-Hydrochlorothiazide | 13 | $327 | $25 |
| Fludrocortisone Acetate | 11 | $211 | $19 |
| Clonidine | 12 | $202 | $17 |
| Lisinopril-Hydrochlorothiazide | 13 | $156 | $12 |
2020: 78 drugs
| Eliquis | 822 | $684,061 | $832 |
| Xarelto | 381 | $373,962 | $982 |
| Entresto | 188 | $144,371 | $768 |
| Pradaxa | 117 | $91,011 | $778 |
| Repatha Sureclick | 62 | $37,940 | $612 |
| Brilinta | 66 | $35,266 | $534 |
| Metoprolol | 882 | $24,816 | $28 |
| Bystolic | 69 | $23,878 | $346 |
| Multaq | 15 | $16,376 | $1,092 |
| Ranolazine Er | 61 | $12,864 | $211 |
| Potassium Chloride | 276 | $12,820 | $46 |
| Edarbi | 44 | $11,191 | $254 |
| Corlanor | 14 | $10,457 | $747 |
| Amiodarone | 121 | $10,366 | $86 |
| Edarbyclor | 32 | $9,530 | $298 |
| Carvedilol Er | 26 | $9,274 | $357 |
| Irbesartan | 222 | $8,425 | $38 |
| Vascepa | 20 | $7,624 | $381 |
| Olmesartan Medoxomil | 138 | $7,519 | $54 |
| Zontivity | 22 | $7,101 | $323 |
| Valsartan | 86 | $6,553 | $76 |
| Clopidogrel | 384 | $6,330 | $16 |
| Atorvastatin | 319 | $5,689 | $18 |
| Praluent | 11 | $5,483 | $498 |
| Chlorthalidone | 107 | $5,386 | $50 |
| Carvedilol | 528 | $5,123 | $10 |
| Flecainide Acetate | 53 | $4,665 | $88 |
| Nitroglycerin | 268 | $4,381 | $16 |
| Amlodipine-Valsartan-Hctz | 29 | $4,296 | $148 |
| Propafenone Hcl Er | 18 | $4,044 | $225 |
| Candesartan-Hydrochlorothiazid | 13 | $4,024 | $310 |
| Prasugrel | 37 | $3,846 | $104 |
| Torsemide | 216 | $3,821 | $18 |
| Amlodipine Besylate | 566 | $3,579 | $6 |
| Digoxin | 112 | $3,476 | $31 |
| Metolazone | 65 | $3,395 | $52 |
| Isosorbide Dinitrate | 25 | $3,259 | $130 |
| Losartan | 254 | $3,210 | $13 |
| Rosuvastatin | 49 | $3,139 | $64 |
| Olmesartan-Hydrochlorothiazide | 48 | $2,904 | $60 |
| Doxazosin Mesylate | 101 | $2,861 | $28 |
| Ezetimibe | 26 | $2,681 | $103 |
| Metoprolol | 317 | $2,612 | $8 |
| Bumetanide | 26 | $2,410 | $93 |
| Tekturna | 11 | $2,335 | $212 |
| Amlodipine-Valsartan | 31 | $2,286 | $74 |
| Irbesartan-Hydrochlorothiazide | 47 | $2,277 | $48 |
| Diltiazem 24hr Er (Cd) | 37 | $1,984 | $54 |
| Furosemide | 314 | $1,971 | $6 |
| Telmisartan | 24 | $1,885 | $79 |
| Lisinopril | 236 | $1,879 | $8 |
| Valsartan-Hydrochlorothiazide | 23 | $1,851 | $80 |
| Isosorbide Mononitrate Er | 60 | $1,638 | $27 |
| Verapamil Er | 33 | $1,478 | $45 |
| Spironolactone | 150 | $1,322 | $9 |
| Hydrochlorothiazide | 194 | $1,264 | $7 |
| Losartan-Hydrochlorothiazide | 20 | $1,128 | $56 |
| Hydralazine | 70 | $1,058 | $15 |
| Diltiazem 24hr Er | 24 | $1,054 | $44 |
| Dilt-Xr | 20 | $1,043 | $52 |
| Nifedipine Er | 11 | $997 | $91 |
| Atenolol | 73 | $939 | $13 |
| Propafenone | 14 | $897 | $64 |
| Klor-Con 10 | 20 | $872 | $44 |
| Isosorbide Mononitrate | 15 | $749 | $50 |
| Pravastatin | 31 | $650 | $21 |
| Sotalol | 16 | $598 | $37 |
| Enalapril Maleate | 14 | $573 | $41 |
| Simvastatin | 64 | $549 | $9 |
| Ramipril | 39 | $544 | $14 |
| Felodipine Er | 13 | $523 | $40 |
| Benazepril | 32 | $360 | $11 |
| Bisoprolol | 14 | $332 | $24 |
| Clonidine | 19 | $285 | $15 |
| Lisinopril-Hydrochlorothiazide | 19 | $272 | $14 |
| Verapamil | 13 | $198 | $15 |
| Lovastatin | 11 | $162 | $15 |
| Warfarin | 12 | $142 | $12 |
2019: 82 drugs
| Eliquis | 648 | $498,115 | $769 |
| Xarelto | 332 | $287,072 | $865 |
| Pradaxa | 108 | $80,744 | $748 |
| Entresto | 110 | $76,615 | $697 |
| Brilinta | 60 | $41,122 | $685 |
| Repatha Sureclick | 43 | $30,906 | $719 |
| Bystolic | 104 | $29,909 | $288 |
| Metoprolol | 881 | $27,865 | $32 |
| Jardiance | 18 | $24,863 | $1,381 |
| Multaq | 16 | $16,365 | $1,023 |
| Ranolazine Er | 46 | $15,818 | $344 |
| Propafenone Hcl Er | 36 | $14,667 | $407 |
| Olmesartan Medoxomil | 132 | $10,055 | $76 |
| Potassium Chloride | 249 | $9,168 | $37 |
| Irbesartan | 279 | $9,060 | $32 |
| Zontivity | 22 | $8,026 | $365 |
| Clopidogrel | 353 | $6,209 | $18 |
| Carvedilol Er | 20 | $5,957 | $298 |
| Candesartan Cilexetil | 50 | $5,874 | $117 |
| Valsartan | 90 | $5,799 | $64 |
| Edarbyclor | 22 | $5,785 | $263 |
| Carvedilol | 557 | $5,730 | $10 |
| Amiodarone | 96 | $5,690 | $59 |
| Atorvastatin | 332 | $5,582 | $17 |
| Enoxaparin | 18 | $5,004 | $278 |
| Nitroglycerin | 299 | $4,713 | $16 |
| Amlodipine Besylate | 573 | $4,296 | $7 |
| Edarbi | 18 | $4,281 | $238 |
| Olmesartan-Hydrochlorothiazide | 55 | $3,995 | $73 |
| Chlorthalidone | 76 | $3,992 | $53 |
| Candesartan-Hydrochlorothiazid | 12 | $3,787 | $316 |
| Digoxin | 91 | $3,743 | $41 |
| Rosuvastatin | 55 | $3,554 | $65 |
| Flecainide Acetate | 60 | $3,434 | $57 |
| Doxazosin Mesylate | 91 | $3,103 | $34 |
| Losartan | 250 | $3,071 | $12 |
| Prasugrel | 28 | $3,036 | $108 |
| Irbesartan-Hydrochlorothiazide | 69 | $3,020 | $44 |
| Ezetimibe | 36 | $2,758 | $77 |
| Metoprolol | 292 | $2,755 | $9 |
| Metolazone | 46 | $2,742 | $60 |
| Amlodipine-Valsartan-Hctz | 14 | $2,738 | $196 |
| Furosemide | 351 | $2,511 | $7 |
| Valsartan-Hydrochlorothiazide | 31 | $2,337 | $75 |
| Isosorbide Dinitrate | 27 | $2,231 | $83 |
| Matzim La | 11 | $2,226 | $202 |
| Lisinopril | 277 | $2,182 | $8 |
| Telmisartan | 18 | $1,825 | $101 |
| Torsemide | 111 | $1,816 | $16 |
| Spironolactone | 168 | $1,541 | $9 |
| Hydralazine | 51 | $1,463 | $29 |
| Atenolol | 86 | $1,305 | $15 |
| Amlodipine-Valsartan | 18 | $1,190 | $66 |
| Verapamil Er | 29 | $1,120 | $39 |
| Pravastatin | 31 | $1,098 | $35 |
| Propafenone | 16 | $1,014 | $63 |
| Diltiazem 24hr Er (Cd) | 18 | $1,006 | $56 |
| Nifedipine Er | 11 | $1,000 | $91 |
| Felodipine Er | 13 | $996 | $77 |
| Losartan-Hydrochlorothiazide | 60 | $993 | $17 |
| Hydrochlorothiazide | 168 | $887 | $5 |
| Cartia Xt | 26 | $849 | $33 |
| Isosorbide Mononitrate Er | 26 | $798 | $31 |
| Sotalol | 29 | $729 | $25 |
| Digox | 20 | $716 | $36 |
| Dilt-Xr | 12 | $704 | $59 |
| Ramipril | 47 | $696 | $15 |
| Enalapril Maleate | 16 | $641 | $40 |
| Isosorbide Mononitrate | 12 | $586 | $49 |
| Diltiazem 24hr Er | 24 | $574 | $24 |
| Simvastatin | 52 | $482 | $9 |
| Benazepril | 41 | $477 | $12 |
| Klor-Con 10 | 12 | $476 | $40 |
| Toprol Xl | 17 | $452 | $27 |
| Lovastatin | 25 | $419 | $17 |
| Amlodipine Besylate-Benazepril | 11 | $372 | $34 |
| Clonidine | 27 | $363 | $13 |
| Lisinopril-Hydrochlorothiazide | 25 | $235 | $9 |
| Warfarin | 16 | $199 | $12 |
| Triamterene-Hydrochlorothiazid | 12 | $191 | $16 |
| Verapamil | 13 | $189 | $15 |
| Sulfamethoxazole-Trimethoprim | 28 | $100 | $4 |
2018: 72 drugs
| Eliquis | 420 | $283,144 | $674 |
| Xarelto | 349 | $248,605 | $712 |
| Pradaxa | 214 | $131,543 | $615 |
| Entresto | 70 | $46,192 | $660 |
| Bystolic | 137 | $33,018 | $241 |
| Metoprolol | 960 | $31,534 | $33 |
| Brilinta | 40 | $26,745 | $669 |
| Ranexa | 37 | $22,085 | $597 |
| Repatha Sureclick | 16 | $17,051 | $1,066 |
| Multaq | 12 | $12,559 | $1,047 |
| Valsartan | 210 | $10,865 | $52 |
| Zontivity | 21 | $9,841 | $469 |
| Irbesartan | 412 | $9,609 | $23 |
| Olmesartan Medoxomil | 71 | $6,887 | $97 |
| Propafenone Hcl Er | 16 | $6,845 | $428 |
| Potassium Chloride | 193 | $6,545 | $34 |
| Prasugrel | 32 | $6,486 | $203 |
| Atorvastatin | 373 | $6,444 | $17 |
| Clopidogrel | 396 | $5,962 | $15 |
| Nitroglycerin | 301 | $5,868 | $19 |
| Valsartan-Hydrochlorothiazide | 160 | $5,782 | $36 |
| Amiodarone | 81 | $4,831 | $60 |
| Amlodipine Besylate | 610 | $4,589 | $8 |
| Carvedilol | 589 | $4,467 | $8 |
| Carvedilol Er | 15 | $4,210 | $281 |
| Metoprolol | 388 | $4,029 | $10 |
| Digoxin | 100 | $3,969 | $40 |
| Flecainide Acetate | 43 | $3,447 | $80 |
| Edarbi | 15 | $3,336 | $222 |
| Rosuvastatin | 48 | $3,091 | $64 |
| Isosorbide Dinitrate | 39 | $3,041 | $78 |
| Ezetimibe | 24 | $2,972 | $124 |
| Irbesartan-Hydrochlorothiazide | 75 | $2,798 | $37 |
| Olmesartan-Hydrochlorothiazide | 46 | $2,685 | $58 |
| Lisinopril | 328 | $2,308 | $7 |
| Losartan | 217 | $2,285 | $11 |
| Furosemide | 382 | $2,214 | $6 |
| Metolazone | 36 | $2,184 | $61 |
| Candesartan Cilexetil | 20 | $2,053 | $103 |
| Digox | 37 | $1,990 | $54 |
| Verapamil Er | 47 | $1,849 | $39 |
| Spironolactone | 178 | $1,790 | $10 |
| Doxazosin Mesylate | 53 | $1,596 | $30 |
| Clonidine | 11 | $1,414 | $129 |
| Mexiletine | 11 | $1,410 | $128 |
| Propafenone | 16 | $1,367 | $85 |
| Atenolol | 114 | $1,307 | $11 |
| Hydralazine | 67 | $1,306 | $19 |
| Pravastatin | 27 | $1,175 | $44 |
| Isosorbide Mononitrate Er | 34 | $987 | $29 |
| Digitek | 19 | $977 | $51 |
| Cartia Xt | 35 | $942 | $27 |
| Isosorbide Mononitrate | 27 | $919 | $34 |
| Losartan-Hydrochlorothiazide | 66 | $913 | $14 |
| Ramipril | 44 | $823 | $19 |
| Toprol Xl | 18 | $808 | $45 |
| Hydrochlorothiazide | 153 | $697 | $5 |
| Nifedipine Er | 16 | $670 | $42 |
| Simvastatin | 59 | $640 | $11 |
| Diltiazem 24hr Er (Cd) | 12 | $610 | $51 |
| Diltiazem 24hr Er | 17 | $493 | $29 |
| Sotalol | 26 | $487 | $19 |
| Triamterene-Hydrochlorothiazid | 37 | $474 | $13 |
| Warfarin | 44 | $473 | $11 |
| Lovastatin | 34 | $454 | $13 |
| Benazepril | 34 | $374 | $11 |
| Clonidine | 37 | $366 | $10 |
| Klor-Con 10 | 13 | $332 | $26 |
| Klor-Con Sprinkle | 14 | $326 | $23 |
| Lisinopril-Hydrochlorothiazide | 23 | $184 | $8 |
| Verapamil | 16 | $115 | $7 |
| Pantoprazole | 17 | $104 | $6 |
2017: 71 drugs
| Xarelto | 342 | $201,124 | $588 |
| Eliquis | 376 | $193,129 | $514 |
| Pradaxa | 300 | $157,350 | $525 |
| Brilinta | 84 | $44,066 | $525 |
| Effient | 60 | $38,722 | $645 |
| Ranexa | 49 | $34,977 | $714 |
| Metoprolol | 1,022 | $31,453 | $31 |
| Bystolic | 162 | $30,542 | $189 |
| Valsartan | 331 | $12,720 | $38 |
| Zetia | 21 | $12,286 | $585 |
| Olmesartan-Hydrochlorothiazide | 57 | $11,319 | $199 |
| Benicar Hct | 23 | $10,194 | $443 |
| Valsartan-Hydrochlorothiazide | 245 | $8,913 | $36 |
| Olmesartan Medoxomil | 44 | $8,829 | $201 |
| Benicar | 22 | $8,268 | $376 |
| Atorvastatin | 453 | $7,692 | $17 |
| Ezetimibe | 17 | $7,591 | $447 |
| Vytorin | 14 | $6,732 | $481 |
| Clopidogrel | 526 | $6,520 | $12 |
| Potassium Chloride | 214 | $5,922 | $28 |
| Amiodarone | 93 | $5,451 | $59 |
| Coreg Cr | 13 | $5,227 | $402 |
| Nitroglycerin | 217 | $5,093 | $23 |
| Isosorbide Dinitrate | 59 | $4,120 | $70 |
| Carvedilol | 541 | $4,056 | $7 |
| Irbesartan | 168 | $3,925 | $23 |
| Digoxin | 90 | $3,906 | $43 |
| Edarbi | 19 | $3,606 | $190 |
| Amlodipine Besylate | 600 | $3,471 | $6 |
| Flecainide Acetate | 45 | $2,916 | $65 |
| Verapamil Er | 74 | $2,862 | $39 |
| Metolazone | 53 | $2,784 | $53 |
| Metoprolol | 440 | $2,694 | $6 |
| Captopril | 12 | $2,223 | $185 |
| Losartan | 216 | $1,998 | $9 |
| Furosemide | 409 | $1,947 | $5 |
| Rosuvastatin | 39 | $1,923 | $49 |
| Lisinopril | 221 | $1,555 | $7 |
| Spironolactone | 174 | $1,537 | $9 |
| Atenolol | 148 | $1,487 | $10 |
| Isosorbide Mononitrate Er | 66 | $1,456 | $22 |
| Diltiazem 24hr Er | 35 | $1,373 | $39 |
| Digitek | 24 | $1,259 | $52 |
| Digox | 36 | $1,244 | $35 |
| Doxazosin Mesylate | 51 | $1,238 | $24 |
| Hydralazine | 67 | $1,209 | $18 |
| Pravastatin | 25 | $1,043 | $42 |
| Propafenone | 13 | $988 | $76 |
| Toprol Xl | 15 | $843 | $56 |
| Nitrostat | 30 | $806 | $27 |
| Losartan-Hydrochlorothiazide | 78 | $766 | $10 |
| Isosorbide Mononitrate | 17 | $718 | $42 |
| Simvastatin | 82 | $663 | $8 |
| Triamterene-Hydrochlorothiazid | 41 | $596 | $15 |
| Irbesartan-Hydrochlorothiazide | 13 | $590 | $45 |
| Ramipril | 37 | $545 | $15 |
| Hydrochlorothiazide | 103 | $438 | $4 |
| Bumetanide | 14 | $434 | $31 |
| Warfarin | 46 | $422 | $9 |
| Sotalol | 20 | $378 | $19 |
| Benazepril | 49 | $369 | $8 |
| Lovastatin | 30 | $356 | $12 |
| Klor-Con 10 | 12 | $323 | $27 |
| Nifedipine Er | 11 | $300 | $27 |
| Pantoprazole | 29 | $293 | $10 |
| Cartia Xt | 11 | $250 | $23 |
| Clonidine | 20 | $224 | $11 |
| Klor-Con M20 | 13 | $193 | $15 |
| Lisinopril-Hydrochlorothiazide | 26 | $150 | $6 |
| Verapamil | 16 | $102 | $6 |
| Sulfamethoxazole-Trimethoprim | 21 | $73 | $3 |
2016: 67 drugs
| Xarelto | 272 | $148,121 | $545 |
| Pradaxa | 287 | $137,386 | $479 |
| Eliquis | 296 | $137,246 | $464 |
| Ranexa | 52 | $37,584 | $723 |
| Brilinta | 88 | $35,848 | $407 |
| Effient | 61 | $33,315 | $546 |
| Benicar Hct | 77 | $29,134 | $378 |
| Metoprolol | 848 | $25,988 | $31 |
| Bystolic | 136 | $24,825 | $183 |
| Benicar | 61 | $21,272 | $349 |
| Multaq | 20 | $20,871 | $1,044 |
| Valsartan | 189 | $17,906 | $95 |
| Zetia | 23 | $12,154 | $528 |
| Crestor | 26 | $9,725 | $374 |
| Propafenone Hcl Er | 11 | $9,003 | $818 |
| Atorvastatin | 443 | $7,571 | $17 |
| Clopidogrel | 485 | $6,255 | $13 |
| Valsartan-Hydrochlorothiazide | 143 | $5,894 | $41 |
| Vytorin | 15 | $5,861 | $391 |
| Nitrostat | 225 | $5,843 | $26 |
| Carvedilol | 509 | $4,104 | $8 |
| Potassium Chloride | 154 | $4,003 | $26 |
| Digoxin | 107 | $3,950 | $37 |
| Metoprolol | 489 | $3,346 | $7 |
| Rosuvastatin | 21 | $3,333 | $159 |
| Amlodipine Besylate | 444 | $3,019 | $7 |
| Captopril | 17 | $2,737 | $161 |
| Metolazone | 33 | $2,352 | $71 |
| Isosorbide Dinitrate | 40 | $2,323 | $58 |
| Verapamil Er | 79 | $1,922 | $24 |
| Edarbi | 12 | $1,918 | $160 |
| Losartan | 179 | $1,775 | $10 |
| Diltiazem 24hr Er | 38 | $1,684 | $44 |
| Furosemide | 342 | $1,589 | $5 |
| Atenolol | 186 | $1,568 | $8 |
| Pravastatin | 37 | $1,527 | $41 |
| Irbesartan | 58 | $1,372 | $24 |
| Digox | 33 | $1,368 | $41 |
| Isosorbide Mononitrate Er | 67 | $1,313 | $20 |
| Spironolactone | 127 | $1,281 | $10 |
| Lisinopril | 174 | $1,279 | $7 |
| Flecainide Acetate | 43 | $1,253 | $29 |
| Digitek | 17 | $1,034 | $61 |
| Amiodarone | 75 | $1,027 | $14 |
| Nitroglycerin | 56 | $946 | $17 |
| Hydralazine | 52 | $918 | $18 |
| Losartan-Hydrochlorothiazide | 74 | $916 | $12 |
| Propafenone | 20 | $882 | $44 |
| Amlodipine-Valsartan | 12 | $841 | $70 |
| Ramipril | 40 | $746 | $19 |
| Simvastatin | 104 | $712 | $7 |
| Amlodipine Besylate-Benazepril | 19 | $703 | $37 |
| Sotalol | 27 | $544 | $20 |
| Doxazosin Mesylate | 29 | $536 | $18 |
| Warfarin | 54 | $511 | $9 |
| Triamterene-Hydrochlorothiazid | 37 | $394 | $11 |
| Isosorbide Mononitrate | 20 | $351 | $18 |
| Klor-Con M20 | 16 | $328 | $20 |
| Diltiazem 24hr Cd | 13 | $319 | $25 |
| Lovastatin | 27 | $304 | $11 |
| Hydrochlorothiazide | 52 | $273 | $5 |
| Klor-Con 10 | 12 | $250 | $21 |
| Benazepril | 29 | $214 | $7 |
| Lisinopril-Hydrochlorothiazide | 34 | $198 | $6 |
| Clonidine | 18 | $187 | $10 |
| Verapamil | 11 | $106 | $10 |
| Sulfamethoxazole-Trimethoprim | 22 | $84 | $4 |
2015: 66 drugs
| Xarelto | 240 | $106,789 | $445 |
| Eliquis | 246 | $102,828 | $418 |
| Pradaxa | 176 | $93,072 | $529 |
| Ranexa | 56 | $38,591 | $689 |
| Metoprolol | 722 | $26,108 | $36 |
| Benicar Hct | 79 | $21,451 | $272 |
| Brilinta | 57 | $18,880 | $331 |
| Effient | 36 | $15,455 | $429 |
| Crestor | 36 | $15,451 | $429 |
| Bystolic | 88 | $14,332 | $163 |
| Propafenone Hcl Er | 20 | $14,116 | $706 |
| Benicar | 45 | $12,782 | $284 |
| Valsartan | 138 | $12,346 | $89 |
| Multaq | 14 | $10,761 | $769 |
| Zetia | 20 | $10,183 | $509 |
| Diovan | 25 | $8,994 | $360 |
| Atorvastatin | 470 | $8,491 | $18 |
| Nitrostat | 401 | $6,233 | $16 |
| Clopidogrel | 396 | $5,331 | $13 |
| Potassium Chloride | 194 | $4,949 | $26 |
| Vytorin | 16 | $4,860 | $304 |
| Digoxin | 122 | $4,844 | $40 |
| Valsartan-Hydrochlorothiazide | 70 | $4,338 | $62 |
| Carvedilol | 450 | $3,868 | $9 |
| Isosorbide Dinitrate | 41 | $3,572 | $87 |
| Metoprolol | 532 | $3,255 | $6 |
| Amlodipine Besylate | 449 | $3,105 | $7 |
| Coreg Cr | 14 | $3,005 | $215 |
| Digox | 55 | $2,679 | $49 |
| Losartan | 180 | $2,042 | $11 |
| Flecainide Acetate | 42 | $1,866 | $44 |
| Verapamil Er | 82 | $1,845 | $23 |
| Atenolol | 202 | $1,781 | $9 |
| Pravastatin | 34 | $1,507 | $44 |
| Lisinopril | 218 | $1,439 | $7 |
| Furosemide | 319 | $1,394 | $4 |
| Irbesartan | 37 | $1,231 | $33 |
| Metolazone | 25 | $1,150 | $46 |
| Diltiazem Er | 12 | $1,114 | $93 |
| Enalapril Maleate | 25 | $1,066 | $43 |
| Digitek | 14 | $1,063 | $76 |
| Isosorbide Mononitrate Er | 59 | $977 | $17 |
| Spironolactone | 107 | $973 | $9 |
| Simvastatin | 119 | $941 | $8 |
| Warfarin | 80 | $868 | $11 |
| Verapamil Sr | 12 | $817 | $68 |
| Amlodipine Besylate-Benazepril | 17 | $767 | $45 |
| Sotalol | 28 | $738 | $26 |
| Ramipril | 36 | $655 | $18 |
| Losartan-Hydrochlorothiazide | 48 | $655 | $14 |
| Toprol Xl | 12 | $638 | $53 |
| Amiodarone | 42 | $609 | $15 |
| Propafenone | 15 | $577 | $38 |
| Hydralazine | 38 | $550 | $14 |
| Fenofibrate | 11 | $531 | $48 |
| Doxazosin Mesylate | 25 | $438 | $18 |
| Triamterene-Hydrochlorothiazid | 35 | $417 | $12 |
| Lisinopril-Hydrochlorothiazide | 31 | $382 | $12 |
| Lovastatin | 31 | $374 | $12 |
| Hydrochlorothiazide | 56 | $333 | $6 |
| Propranolol | 11 | $319 | $29 |
| Klor-Con M20 | 17 | $254 | $15 |
| Benazepril | 28 | $223 | $8 |
| Omeprazole | 17 | $191 | $11 |
| Fosinopril | 16 | $176 | $11 |
| Ranitidine | 13 | $83 | $6 |
2014: 73 drugs
| Pradaxa | 191 | $88,413 | $463 |
| Xarelto | 181 | $63,501 | $351 |
| Ranexa | 45 | $26,112 | $580 |
| Diovan | 116 | $25,426 | $219 |
| Metoprolol | 568 | $22,311 | $39 |
| Eliquis | 54 | $21,073 | $390 |
| Benicar Hct | 70 | $16,016 | $229 |
| Multaq | 30 | $15,749 | $525 |
| Bystolic | 103 | $14,561 | $141 |
| Propafenone Hcl Er | 19 | $13,831 | $728 |
| Brilinta | 37 | $13,020 | $352 |
| Crestor | 39 | $12,566 | $322 |
| Effient | 29 | $12,173 | $420 |
| Zetia | 22 | $10,819 | $492 |
| Clopidogrel | 477 | $10,236 | $21 |
| Atorvastatin | 349 | $8,353 | $24 |
| Benicar | 32 | $7,841 | $245 |
| Valsartan-Hydrochlorothiazide | 60 | $6,283 | $105 |
| Nitrostat | 448 | $5,898 | $13 |
| Exforge | 28 | $5,872 | $210 |
| Isosorbide Dinitrate | 48 | $4,592 | $96 |
| Carvedilol | 399 | $4,279 | $11 |
| Digoxin | 103 | $4,224 | $41 |
| Coreg Cr | 16 | $3,596 | $225 |
| Potassium Chloride | 130 | $3,495 | $27 |
| Digox | 85 | $3,456 | $41 |
| Metoprolol | 421 | $3,193 | $8 |
| Amlodipine Besylate | 394 | $3,013 | $8 |
| Valsartan | 18 | $2,839 | $158 |
| Vytorin | 14 | $2,665 | $190 |
| Lovaza | 13 | $2,407 | $185 |
| Amlodipine Besylate-Benazepril | 32 | $2,339 | $73 |
| Tekturna | 14 | $1,959 | $140 |
| Verapamil Er | 79 | $1,899 | $24 |
| Amiodarone | 31 | $1,865 | $60 |
| Flecainide Acetate | 41 | $1,852 | $45 |
| Atenolol | 182 | $1,834 | $10 |
| Lisinopril | 213 | $1,579 | $7 |
| Simvastatin | 145 | $1,385 | $10 |
| Isosorbide Mononitrate Er | 68 | $1,363 | $20 |
| Pravastatin | 41 | $1,358 | $33 |
| Furosemide | 277 | $1,294 | $5 |
| Losartan | 91 | $1,134 | $12 |
| Captopril | 12 | $1,105 | $92 |
| Warfarin | 79 | $962 | $12 |
| Irbesartan | 33 | $897 | $27 |
| Propafenone | 22 | $875 | $40 |
| Klor-Con M20 | 20 | $864 | $43 |
| Klor-Con 10 | 25 | $859 | $34 |
| Spironolactone | 91 | $854 | $9 |
| Metolazone | 25 | $805 | $32 |
| Toprol Xl | 16 | $788 | $49 |
| Ramipril | 30 | $687 | $23 |
| Fenofibrate | 13 | $628 | $48 |
| Sotalol | 24 | $622 | $26 |
| Verapamil Sr | 12 | $535 | $45 |
| Hydralazine | 32 | $530 | $17 |
| Doxazosin Mesylate | 26 | $499 | $19 |
| Omeprazole | 20 | $488 | $24 |
| Lisinopril-Hydrochlorothiazide | 40 | $452 | $11 |
| Losartan-Hydrochlorothiazide | 27 | $447 | $17 |
| Diltiazem 24hr Cd | 14 | $403 | $29 |
| Klor-Con 8 | 20 | $391 | $20 |
| Hydrochlorothiazide | 52 | $334 | $6 |
| Lovastatin | 21 | $301 | $14 |
| Enalapril Maleate | 20 | $291 | $15 |
| Diltiazem | 12 | $265 | $22 |
| Triamterene-Hydrochlorothiazid | 14 | $242 | $17 |
| Benazepril | 18 | $239 | $13 |
| Torsemide | 11 | $181 | $16 |
| Pantoprazole | 17 | $165 | $10 |
| Sulfamethoxazole-Trimethoprim | 21 | $75 | $4 |
| Ranitidine | 12 | $72 | $6 |
2013: 67 drugs
| Pradaxa | 254 | $102,980 | $405 |
| Xarelto | 103 | $33,513 | $325 |
| Diovan | 122 | $23,398 | $192 |
| Clopidogrel | 491 | $22,353 | $46 |
| Metoprolol | 512 | $22,135 | $43 |
| Ranexa | 42 | $17,128 | $408 |
| Bystolic | 118 | $13,365 | $113 |
| Zetia | 44 | $12,635 | $287 |
| Propafenone | 33 | $12,461 | $378 |
| Multaq | 27 | $11,110 | $411 |
| Effient | 30 | $10,508 | $350 |
| Atorvastatin | 285 | $9,441 | $33 |
| Crestor | 34 | $9,022 | $265 |
| Benicar | 51 | $8,621 | $169 |
| Valsartan-Hydrochlorothiazide | 64 | $8,256 | $129 |
| Benicar Hct | 27 | $8,160 | $302 |
| Tekturna | 31 | $6,543 | $211 |
| Metoprolol | 516 | $4,368 | $8 |
| Carvedilol | 340 | $4,366 | $13 |
| Tekturna Hct | 19 | $4,006 | $211 |
| Coreg Cr | 19 | $3,986 | $210 |
| Potassium Chloride | 146 | $3,646 | $25 |
| Amlodipine Besylate | 346 | $3,366 | $10 |
| Nitrostat | 282 | $3,288 | $12 |
| Nexium | 14 | $3,204 | $229 |
| Amlodipine Besylate-Benazepril | 20 | $2,984 | $149 |
| Verapamil Er | 85 | $2,905 | $34 |
| Brilinta | 11 | $2,623 | $238 |
| Isosorbide Dinitrate | 27 | $2,604 | $96 |
| Atenolol | 209 | $2,445 | $12 |
| Irbesartan | 39 | $2,406 | $62 |
| Lisinopril | 190 | $1,931 | $10 |
| Vytorin | 11 | $1,846 | $168 |
| Simvastatin | 161 | $1,760 | $11 |
| Lovaza | 13 | $1,711 | $132 |
| Lipitor | 12 | $1,630 | $136 |
| Warfarin | 115 | $1,555 | $14 |
| Losartan | 91 | $1,418 | $16 |
| Furosemide | 249 | $1,239 | $5 |
| Digox | 120 | $1,092 | $9 |
| Pravastatin | 60 | $1,085 | $18 |
| Isosorbide Mononitrate Er | 54 | $1,005 | $19 |
| Klor-Con M20 | 24 | $988 | $41 |
| Omeprazole | 22 | $914 | $42 |
| Metolazone | 34 | $909 | $27 |
| Spironolactone | 79 | $875 | $11 |
| Flecainide Acetate | 26 | $838 | $32 |
| Toprol Xl | 13 | $770 | $59 |
| Ramipril | 42 | $676 | $16 |
| Amiodarone | 44 | $658 | $15 |
| Digoxin | 56 | $627 | $11 |
| Losartan-Hydrochlorothiazide | 20 | $627 | $31 |
| Sotalol | 21 | $603 | $29 |
| Fenofibrate | 11 | $531 | $48 |
| Klor-Con 8 | 26 | $495 | $19 |
| Lisinopril-Hydrochlorothiazide | 28 | $403 | $14 |
| Lovastatin | 30 | $398 | $13 |
| Doxazosin Mesylate | 39 | $369 | $9 |
| Enalapril Maleate | 29 | $363 | $13 |
| Hydrochlorothiazide | 41 | $318 | $8 |
| Hydralazine | 15 | $295 | $20 |
| Pantoprazole | 18 | $267 | $15 |
| Triamterene-Hctz | 16 | $255 | $16 |
| Benazepril | 19 | $226 | $12 |
| Triamterene-Hydrochlorothiazid | 13 | $125 | $10 |
| Sulfamethoxazole-Trimethoprim | 19 | $94 | $5 |
| Ranitidine | 11 | $66 | $6 |
Money from drug and device companies
$684 in 2025
| 2025 | 13 | 48 | None | $684 |
| 2024 | 17 | 69 | None | $1,529 |
| 2023 | 22 | 90 | None | $2,188 |
| 2022 | 17 | 67 | None | $1,727 |
| 2021 | 11 | 32 | None | $771 |
| 2020 | 13 | 40 | None | $1,049 |
| 2019 | 16 | 71 | None | $2,199 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Amgen | Repatha | $148 | 22 payments
|
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Lifevest | $113 | 6 payments
|
| Kestra Medical Technology Services | Assure Wcd | $58 | 3 payments
|
| Alnylam Pharmaceuticals | Amvuttra | $49 | 2 payments
|
| Pfizer | Vyndaqel | $48 | 2 payments
|
| Merck Sharp & Dohme | Verquvo | $42 | 2 payments
|
See all 48 published payments
| Amgen | Meals · 2025-12-12 | Repatha | $8 |
| Tempus AI | Meals · 2025-12-10 | Xt Cdx | $23 |
| Bayer Healthcare Pharmaceuticals | Meals · 2025-12-02 | Kerendia | $27 |
| Amgen | Meals · 2025-11-21 | Repatha | $10 |
| Amgen | Meals · 2025-11-14 | Repatha | $8 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Meals · 2025-11-04 | Lifevest | $16 |
| Amgen | Meals · 2025-10-24 | Repatha | $7 |
| Amgen | Meals · 2025-10-10 | Repatha | $5 |
| Pfizer | Meals · 2025-09-23 | Vyndaqel | $22 |
| Alnylam Pharmaceuticals | Meals · 2025-09-10 | Amvuttra | $23 |
| Bayer Healthcare Pharmaceuticals | Meals · 2025-09-10 | Kerendia | $15 |
| Boehringer Ingelheim Pharmaceuticals | Meals · 2025-09-09 | Jardiance | $18 |
| Merck Sharp & Dohme | Meals · 2025-09-08 | Verquvo | $19 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Meals · 2025-09-03 | Lifevest | $17 |
| Amgen | Meals · 2025-08-25 | Repatha | $6 |
| Pfizer | Meals · 2025-08-21 | Vyndaqel | $26 |
| Amgen | Meals · 2025-08-04 | Repatha | $6 |
| Kestra Medical Technology Services | Meals · 2025-08-01 | Assure Wcd | $24 |
| Amgen | Meals · 2025-07-18 | Repatha | $8 |
| Amgen | Meals · 2025-07-10 | Repatha | $3 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Meals · 2025-06-18 | Lifevest | $22 |
| Amgen | Meals · 2025-06-12 | Repatha | $8 |
| Abbott Laboratories | Meals · 2025-06-06 | Eterna | $21 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-06-05 | Eliquis | $22 |
| Amgen | Meals · 2025-06-02 | Repatha | $7 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-05-20 | Wainua | $18 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-05-19 | Lokelma | $16 |
| Amgen | Meals · 2025-05-19 | Repatha | $5 |
| Amgen | Meals · 2025-05-07 | Repatha | $9 |
| Amgen | Meals · 2025-05-01 | Repatha | $8 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Meals · 2025-04-22 | Lifevest | $23 |
| Amgen | Meals · 2025-04-10 | Repatha | $4 |
| Kestra Medical Technology Services | Meals · 2025-03-26 | Assure Wcd | $15 |
| Abiomed | Meals · 2025-03-25 | None | $31 |
| Amgen | Meals · 2025-03-25 | Repatha | $5 |
| Boehringer Ingelheim Pharmaceuticals | Meals · 2025-03-24 | Jardiance | $16 |
| Merck Sharp & Dohme | Meals · 2025-03-24 | Verquvo | $24 |
| Amgen | Meals · 2025-03-14 | Repatha | $15 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Meals · 2025-03-06 | Lifevest | $19 |
| Alnylam Pharmaceuticals | Meals · 2025-02-26 | Amvuttra | $26 |
| Amgen | Meals · 2025-02-21 | Repatha | $6 |
| Amgen | Meals · 2025-01-31 | Repatha | $3 |
| Kestra Medical Technology Services | Meals · 2025-01-30 | Assure Wcd | $20 |
| Amgen | Meals · 2025-01-27 | Repatha | $5 |
| Amgen | Meals · 2025-01-14 | Repatha | $6 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Meals · 2025-01-07 | Lifevest | $15 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-01-07 | Camzyos | $18 |
| Amgen | Meals · 2025-01-03 | Repatha | $7 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $1,529
| Amgen | Repatha | $555 | 27 payments
|
| Kestra Medical Technology Services | Assure Wcd | $135 | 9 payments
|
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Lifevest | $129 | 8 payments
|
| E.R. Squibb & Sons L.L.C. | Eliquis | $120 | 5 payments
|
| Abbott Laboratories | Merlin@Home | $119 | 1 payment
|
| Merck Sharp & Dohme | Verquvo | $90 | 4 payments
|
| Medtronic | Azure Xt Dr Mri Surescan | $89 | 1 payment
|
| Pfizer | Vyndaqel | $56 | 3 payments
|
| Kiniksa Pharmaceuticals International plc | Arcalyst | $50 | 2 payments
|
| Alnylam Pharmaceuticals | Onpattro | $38 | 2 payments
|
| CVRx | Barostim Neo System | $31 | 1 payment
|
| Boehringer Ingelheim Pharmaceuticals | Jardiance | $24 | 1 payment
|
| Novartis Pharmaceuticals | Leqvio | $22 | 1 payment
|
| AstraZeneca Pharmaceuticals LP | Farxiga | $20 | 1 payment
|
| Janssen Pharmaceuticals | Xarelto | $19 | 1 payment
|
| Daiichi Sankyo | Injectafer | $17 | 1 payment
|
| Novo Nordisk | None | $14 | 1 payment
|
2023: $2,188
| Amgen | Repatha | $726 | 35 payments
|
| Medtronic | Azure Xt Dr Mri Surescan | $448 | 6 payments
|
| Boehringer Ingelheim Pharmaceuticals | Jardiance | $134 | 7 payments
|
| Merck Sharp & Dohme | Verquvo | $119 | 6 payments
|
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Lifevest | $103 | 6 payments
|
| Boston Scientific | None | $102 | 1 payment
|
| Pfizer | Eliquis | $99 | 6 payments
|
| CVRx | Barostim Neo System | $59 | 2 payments
|
| Kiniksa Pharmaceuticals | Arcalyst | $48 | 2 payments
|
| Janssen Pharmaceuticals | Xarelto | $47 | 2 payments
|
| Novartis Pharmaceuticals | Entresto | $47 | 3 payments
|
| E.R. Squibb & Sons L.L.C. | Camzyos | $44 | 2 payments
|
| Novo Nordisk | None | $37 | 2 payments
|
| iRhythm Technologies | Zio Xt Patch | $36 | 2 payments
|
| Daiichi Sankyo | Injectafer | $21 | 1 payment
|
| Abbott Laboratories | Coroflow | $20 | 1 payment
|
| Regeneron Healthcare Solutions | Praluent | $20 | 1 payment
|
| Inspire Medical Systems | Inspire | $19 | 1 payment
|
| Baxter Healthcare | Hillrom - Carnation Ambulatory Monitor | $17 | 1 payment
|
| Lexicon Pharmaceuticals | Inpefa | $16 | 1 payment
|
| Scpharmaceuticals | Furoscix | $15 | 1 payment
|
| AstraZeneca Pharmaceuticals LP | Farxiga | $13 | 1 payment
|
2022: $1,727
| Amgen | Repatha | $628 | 26 payments
|
| Boston Scientific | Lux-Dx Insertable Cardiac Monitor | $223 | 2 payments
|
| Novartis Pharmaceuticals | Entresto | $176 | 4 payments
|
| E.R. Squibb & Sons L.L.C. | Eliquis | $140 | 4 payments
|
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Lifevest | $94 | 6 payments
|
| Merck Sharp & Dohme | Verquvo | $75 | 4 payments
|
| Boehringer Ingelheim Pharmaceuticals | Jardiance | $66 | 3 payments
|
| Pfizer | Eliquis | $54 | 3 payments
|
| Janssen Pharmaceuticals | Xarelto | $49 | 3 payments
|
| Bayer HealthCare Pharmaceuticals | Verquvo | $41 | 3 payments
|
| Kiniksa Pharmaceuticals | Arcalyst | $37 | 2 payments
|
| Kowa Pharmaceuticals America | Livalo | $36 | 2 payments
|
| Abbott Laboratories | Mitraclip | $25 | 1 payment
|
| Astellas Pharma US | Lexiscan | $23 | 1 payment
|
| CVRx | Barostim Neo System | $22 | 1 payment
|
| Esperion Therapeutics | Nexletol | $21 | 1 payment
|
| Arbor Pharmaceuticals | Edarbyclor | $17 | 1 payment
|
2021: $771
| Amgen | Repatha | $279 | 14 payments
|
| Medtronic | Reveal Linq | $133 | 1 payment
|
| Boston Scientific | Lux-Dx | $91 | 1 payment
|
| Boehringer Ingelheim Pharmaceuticals | Jardiance | $52 | 3 payments
|
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Lifevest | $42 | 4 payments
|
| Esperion Therapeutics | Nexletol | $41 | 2 payments
|
| Janssen Pharmaceuticals | Xarelto | $36 | 2 payments
|
| Edwards Lifesciences | None | $31 | 1 payment
|
| Novartis Pharmaceuticals | Entresto | $27 | 2 payments
|
| Pfizer | Eliquis | $21 | 1 payment
|
| AstraZeneca Pharmaceuticals LP | Farxiga | $19 | 1 payment
|
2020: $1,049
| Amgen | Repatha | $354 | 20 payments
|
| Medtronic Vascular | Reveal Linq | $298 | 3 payments
|
| Boston Scientific | Latitude | $141 | 2 payments
|
| Esperion Therapeutics | Nexletol | $42 | 2 payments
|
| Abbott Laboratories | Mitra Clip System | $36 | 2 payments
|
| Akcea Therapeutics | Tegsedi | $34 | 2 payments
|
| Janssen Pharmaceuticals | Xarelto | $32 | 2 payments
|
| AstraZeneca Pharmaceuticals LP | Farxiga | $30 | 2 payments
|
| Novartis Pharmaceuticals | Entresto | $19 | 1 payment
|
| Astellas Pharma US | Lexiscan | $16 | 1 payment
|
| Philips Electronics North America | (7999) Src Undivided | $16 | 1 payment
|
| Arbor Pharmaceuticals | Edarbi | $16 | 1 payment
|
| Pfizer | Eliquis | $15 | 1 payment
|
2019: $2,199
| Amgen | Repatha | $583 | 26 payments
|
| Boston Scientific | General Brady | $445 | 5 payments
|
| Biotronik | None | $278 | 2 payments
|
| Akcea Therapeutics | Tegsedi | $176 | 1 payment
|
| Abbott Laboratories | Cardiomems Hf System | $128 | 2 payments
|
| Sanofi-Aventis U.S. | Praluent | $90 | 5 payments
|
| Boehringer Ingelheim Pharmaceuticals | Pradaxa | $79 | 4 payments
|
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Lifevest | $61 | 4 payments
|
| Pfizer | Eliquis | $57 | 4 payments
|
| Janssen Pharmaceuticals | Xarelto | $56 | 4 payments
|
| Novartis Pharmaceuticals | Entresto | $50 | 3 payments
|
| Lundbeck | Northera | $49 | 2 payments
|
| Astellas Pharma US | Lexiscan | $49 | 3 payments
|
| Arbor Pharmaceuticals | Edarbi | $36 | 2 payments
|
| Gilead Sciences | None | $33 | 2 payments
|
| AstraZeneca Pharmaceuticals LP | Brilinta | $30 | 2 payments
|
Research money
Money a company paid to run a study. Where it went to their institution, the clinician is named as an investigator and did not receive it; the amount covers the whole study, often across many sites.
| Abbott Laboratories · St. Jude Medical Product Longevity and Performance (Score) Registry · 2019 | Their institution | $1,169 |
| Abbott Laboratories · St. Jude Medical Product Longevity and Performance (Score) Registry · 2020 | Their institution | $1,169 |
| Abbott Laboratories · St. Jude Medical Product Longevity and Performance (Score) Registry · 2019 | This clinician | $440 |
Checkups this office reported
9 measures · 2023
Medicare asked this office to report how often certain checkups happened in 2023. This is not a grade for the doctor. A specialist’s patients may not need every screening.
- Medicare’s overall office score
- 76.3 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
| Asked about smokingPatients asked about tobacco, with help to quit if they smoke | 34%That's less than half. | 2,577 |
| Blood pressure under controlPeople with high blood pressure whose reading was in a healthy range | 70%That's more than half. | 3,426 |
| Coronary Artery Disease (CAD): Beta-Blocker Therapy Prior Myocardial Infarction (MI) or Left Ventricular Systolic Dysfunction (LVEF <= 40%)As Medicare defines this measure | 66% | 124 |
| Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) or Angiotensin Receptor-Neprilysin Inhibitor (ARNI) Therapy for Left Ventricular Systolic Dysfunction (LVSD)As Medicare defines this measure | 84% | 90 |
| Heart Failure (HF): Beta-Blocker Therapy for Left Ventricular Systolic Dysfunction (LVSD)As Medicare defines this measure | 78% | 58 |
| Medications listed in the chartVisits where the current medication list was documented | 96%That's most of the people this applied to. | 9,272 |
| Patients can see their records onlinePatients who were given electronic access to their health information | 44%That's less than half. | 1,819 |
| Risky medications in older adultsOlder patients given a medication that is risky at their age | 0%That's few of the people this applied to. Better on this measure. | 3,368 |
See the other 1 measures
| Screening for High Blood Pressure and Follow-Up DocumentedAs Medicare defines this measure | 25% | 3,197 |
What the office says it does
Boxes the office ticked on its Medicare worksheet for 2023. Nobody checks these.
- Agreed to federal review of their records system
- Completion of an Accredited Safety or Quality Improvement Program
- Did a security review of patient data
- Exchanges records both ways with other health systems
- High Priority Practices Guide of the Safety Assurance Factors for EHR Resilience (SAFER) Guides
- Improved the patient portal
- Reports to a public-health or clinical registry
- Reports to public-health surveillance
- Uses standard treatment protocols
- Exempt from electronic case reporting
- Exempt from immunization registry reporting
- Exempt from query of the prescription drug monitoring program (pdmp)
Professional record
- NPI
- 1598758468
- Licence
- CA A44967California A44967: Current · expires 2028-05-31
- Gender
- Male
More record details
- Sole proprietor
- No
- Medicaid ID
- CA 00A449670
- Taxonomy
- Federal specialty code 207RI0011X (207RI0011X)
- Mailing address
- 30 River Park Pl W, Suite #440, Fresno, CA, 93720
- NPI first listed
- 2005-08-25
- NPI last updated
- 2012-09-27
This is when the NPI record was last certified, not a medical board exam.